{
  "meta": {
    "title": "00059_Late_Night_Pyq_Pyt_Marathon_-_59",
    "url": "https://brainandscalpel.vercel.app/00059-late-night-pyq-pyt-marathon-59-168c9de0.html",
    "scrapedAt": "2025-11-29T17:25:05.157Z"
  },
  "questions": [
    {
      "id": 10351,
      "choices": [
        {
          "id": 41370,
          "text": "<p><span style=\"font-size:12.0pt;\">Interstitial keratitis, 8th nerve deafness, mulberry molars</span></p>"
        },
        {
          "id": 41371,
          "text": "<p><span style=\"font-size:12.0pt;\">Interstitial keratitis, 8th nerve deafness, Hutchinson molars</span></p>"
        },
        {
          "id": 41372,
          "text": "<p><span style=\"font-size:12.0pt;\">Interstitial keratitis, 8th nerve deafness, mulberry incisors</span></p>"
        },
        {
          "id": 41373,
          "text": "<p><span style=\"font-size:12.0pt;\">Interstitial keratitis, 8th nerve deafness, Hutchinson incisors</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following constitutes Hutchinson's triad? (AIIMS NOV 2017)</span></p>",
      "unique_key": "Q4727814",
      "question_audio": null,
      "question_video": null,
      "map_id": 13734987,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Interstitial keratitis, 8th nerve deafness, Hutchinson incisors</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Hutchinson's triad refers to:</strong></span></p><p>&nbsp;</p><ol style=\"list-style-type:upper-roman;\"><li><span style=\"font-size:12.0pt;\">Interstitial keratitis</span></li><li><span style=\"font-size:12.0pt;\">8th nerve deafness</span></li><li><span style=\"font-size:12.0pt;\">Hutchinson incisors</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Commonly seen in <strong>late congenital syphilis.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/101.jpg\" alt=\"\" width=\"500\" height=\"330\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Features of Hutchinson Teeth:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Peg-shaped with a crescent-shaped notch</span></li><li><span style=\"font-size:12.0pt;\">Thinning or discoloration of enamel</span></li><li><span style=\"font-size:12.0pt;\">Smaller teeth</span></li><li><span style=\"font-size:12.0pt;\">Widely spaced teeth</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Mulberry molars:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Mulberry molars (also known as Moon or Fournier molars) are also seen in Congenital Syphilis. They are multicuspid first molars in which the tooth's grinding surface, which is narrower than that at the gingival margin, has many small cusps instead of the usual four well-formed cusps.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/08/untitled-201.jpg\" alt=\"\" width=\"400\" height=\"306\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Interstitial keratitis, 8th nerve deafness, mulberry molars:</strong> Mulberry molars are also seen in congenital syphilis but are not part of Hutchinson's triad. Mulberry molars (also known as Moon or Fournier molars) are first molars with a narrower grinding surface and multiple small cusps rather than the usual four well-formed cusps.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Interstitial keratitis, 8th nerve deafness, Hutchinson molars:</strong> The correct dental component of Hutchinson's triad is Hutchinson incisors, not molars.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Interstitial keratitis, 8th nerve deafness, mulberry incisors:</strong> The term \"mulberry incisors\" is not accurate; Hutchinson incisors are the correct term, which refers to the characteristic dental deformity in Hutchinson's triad.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Hutchinson's triad consists of interstitial keratitis, 8th nerve deafness, and Hutchinson incisors, and it is a diagnostic feature of late congenital syphilis.</span></p>",
      "correct_choice_id": 41373,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "CriteriaBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20337,
      "choices": [
        {
          "id": 81309,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute epiglottitis</span></p>"
        },
        {
          "id": 81310,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute laryngotracheobronchitis</span></p>"
        },
        {
          "id": 81311,
          "text": "<p><span style=\"font-size:12.0pt;\">Foreign body in glottis</span></p>"
        },
        {
          "id": 81312,
          "text": "<p><span style=\"font-size:12.0pt;\">Laryngomalacia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A child is brought to the hospital with features of respiratory distress and biphasic stridor. There is a history of upper respiratory infection. The radiograph is shown below. Mark the correct diagnosis? (NEET PG 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/01/whatsapp-image-2023-06-12-at-19012100.jpg\" alt=\"\" width=\"300\" height=\"300\"></span></p>",
      "unique_key": "Q1619053",
      "question_audio": null,
      "question_video": null,
      "map_id": 13734988,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Acute laryngotracheobronchitis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A child with respiratory distress and biphasic stridor and given radiograph points to a diagnosis of acute laryngotracheobronchitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/01/whatsapp-image-2023-06-12-at-19012101.jpg\" alt=\"\" width=\"700\" height=\"713\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">LARYNGOTRACHEOBRONCHITIS (CROUP)</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Viral infection of glottis &amp; subglottic region</span></li><li><span style=\"font-size:12.0pt;\">Caused by Parainfluenza virus</span></li><li><span style=\"font-size:12.0pt;\">Symptoms: hoarse voice, coryza, mild Tachypnea</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Treatment –</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Nebulized racemic adrenaline (1:1 mixture of d &amp; I isomers)</span></li><li><span style=\"font-size:12.0pt;\">A single dose of dexamethasone (0.3--0.6 mg/kg, intramuscular) reduces seventy, if given within the first 24 hours.</span></li><li><span style=\"font-size:12.0pt;\">Antibiotics not indicated</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">NOTE -</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Croup decreases in lying down position and Laryngomalacia increases on lying down</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Acute epiglottitis</strong>: Acute epiglottitis patients, usually 3-6 years of age, present with acute sore throat, high fever, muffled voice, inspiratory stridor, marked dysphagia and drooling. The patient looks toxic and sits in tripod position, sitting upright, leaning forward with chin up. Treatment is IV Ceftriaxone. Lateral neck X-ray reveals thickening of the epiglottis (thumb print sign).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/01/whatsapp-image-2023-06-12-at-19012102.jpg\" alt=\"\" width=\"700\" height=\"391\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Foreign body in glottis</strong>: Aspiration of foreign body may result in localized area of wheeze, hyperresonance and reduced air entry. Foreign bodies are removed through a rigid bronchoscope.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Laryngomalacia</strong>: Laryngomalacia is M/C cause of congenital laryngeal anomaly.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/16/screenshot-2024-09-16-152312.png\" alt=\"\" width=\"1000\" height=\"486\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Acute laryngotracheobronchitis (croup) is a viral infection of the glottis and subglottic region, often caused by the Parainfluenza virus, and presents with respiratory distress and biphasic stridor.</span></p>",
      "correct_choice_id": 81310,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54652,
      "choices": [
        {
          "id": 218073,
          "text": "<p><span style=\"font-size:12.0pt;\">Delayed skin pinch</span></p>"
        },
        {
          "id": 218074,
          "text": "<p><span style=\"font-size:12.0pt;\">Sunken eyeballs</span></p>"
        },
        {
          "id": 218075,
          "text": "<p><span style=\"font-size:12.0pt;\">Lethargy</span></p>"
        },
        {
          "id": 218076,
          "text": "<p><span style=\"font-size:12.0pt;\">None of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not a sign of some dehydration in a 5-year-old child?&nbsp;</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q2047472",
      "question_audio": null,
      "question_video": null,
      "map_id": 13734989,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;C) Lethargy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Lethargy is a sign of severe dehydration, not some dehydration. In the context of dehydration, it is important to differentiate between signs that indicate mild to moderate (some) dehydration and those that suggest severe dehydration. Lethargy indicates a more serious state of fluid loss that affects the child's overall responsiveness and energy levels, which is not characteristic of mild or moderate dehydration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Delayed skin pinch:</strong> This sign can occur in both some and severe dehydration. When the skin, typically on the abdomen or arm, is pinched and it returns to its original position slowly, it indicates decreased skin turgor, a common sign of dehydration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Sunken eyeballs:</strong> Sunken eyes can be a symptom of both some and severe dehydration. It is a visible sign that reflects reduced fluid in the body, causing the eyes to appear sunken.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. None of the above:</strong> This option is incorrect because one of the choices (lethargy) is not a sign of some dehydration but rather severe dehydration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Lethargy is a sign of severe dehydration, whereas delayed skin pinch and sunken eyeballs can be signs of both some and severe dehydration in a 5-year-old child.</span></p>",
      "correct_choice_id": 218075,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10265,
      "choices": [
        {
          "id": 41026,
          "text": "<p><span style=\"font-size:12.0pt;\">Hopping on one foot</span></p>"
        },
        {
          "id": 41027,
          "text": "<p><span style=\"font-size:12.0pt;\">Spoon handling</span></p>"
        },
        {
          "id": 41028,
          "text": "<p><span style=\"font-size:12.0pt;\">Copying a triangle</span></p>"
        },
        {
          "id": 41029,
          "text": "<p><span style=\"font-size:12.0pt;\">Repeats sentence of 10 syllables</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following milestones would you generally expect a 3-year-old child to display? (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q5326830",
      "question_audio": null,
      "question_video": null,
      "map_id": 13734990,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Spoon handling</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">By the age of 24 months (2 years), most children develop the ability to use a spoon and feed themselves, which is a key fine motor skill. By the age of 3 years, this skill is typically well established, allowing the child to handle a spoon with greater proficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Hopping on one foot</strong>: Hopping on one foot is a motor milestone that typically develops around the age of 4 years. Skipping usually comes later, around 5 years.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Copying a triangle</strong>: The ability to copy shapes such as a triangle is generally seen around 5 years of age. More complex shapes like a diamond are usually copied around 7 years of age.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Repeats sentences of 10 syllables</strong>: A child's ability to repeat longer sentences, including those with 10 syllables, generally develops around 4 to 5 years of age.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">By the age of 3 years, a child is typically expected to handle a spoon and feed themselves, while more complex motor and language skills develop later.</span></p>",
      "correct_choice_id": 41027,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10169,
      "choices": [
        {
          "id": 40642,
          "text": "<p><span style=\"font-size:12.0pt;\">Death occurs in 3rd decade</span></p>"
        },
        {
          "id": 40643,
          "text": "<p><span style=\"font-size:12.0pt;\">Previous history of viral prodrome</span></p>"
        },
        {
          "id": 40644,
          "text": "<p><span style=\"font-size:12.0pt;\">It is a mitochondrial storage disorder</span></p>"
        },
        {
          "id": 40645,
          "text": "<p><span style=\"font-size:12.0pt;\">Early treatment has excellent prognosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An 8-year-old child has difficulty walking and getting up from a squatting position. A muscle biopsy was done and is as shown in the image. Which of the following is true about this condition? (NEET PG 2022)</span></p><p>&nbsp;</p><p><span style=\"font-size:10.5pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/7_PbNVvG8.jpg\" alt=\"\" width=\"300\" height=\"208\"></span></p>",
      "unique_key": "Q5629056",
      "question_audio": null,
      "question_video": null,
      "map_id": 13761924,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Death occurs in 3<sup>rd</sup> decade</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical scenario and the muscle biopsy showing fatty replacement of muscle fibers are suggestive of Duchenne muscular dystrophy (DMD). Death in DMD occurs in the late teens and 20s (3rd decade).</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/28/picture140.jpg\" alt=\"\" width=\"1000\" height=\"692\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Gower sign:</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/17/untitled-460.jpg\" alt=\"\" width=\"400\" height=\"345\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Previous history of viral prodrome:&nbsp;</strong>This option is not correct. DMD is a genetic disorder and does not typically have a history of a viral prodrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. It is a mitochondrial storage disorder:&nbsp;</strong>This option is incorrect. DMD is not a mitochondrial storage disorder; it is caused by mutations in the dystrophin gene.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Early treatment has excellent prognosis:&nbsp;</strong>While early treatment with corticosteroids can help manage symptoms and slow disease progression, DMD remains a progressive and fatal disease with current treatments. Thus, early treatment does not lead to an \"excellent\" prognosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Duchenne muscular dystrophy (DMD) is a genetic disorder characterized by progressive muscle weakness, and death typically occurs in the late teens to early 20s.</span></p>",
      "correct_choice_id": 40642,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61857,
      "choices": [
        {
          "id": 246697,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Square root of height in feet by weight in grams</span></span></span></p>"
        },
        {
          "id": 246698,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Weight in kilograms by cube of height in meters</span></span></span></p>"
        },
        {
          "id": 246699,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mid-upper arm circumference to head circumference ratio</span></span></span></p>"
        },
        {
          "id": 246700,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Head circumference to abdominal circumference ratio</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ponderal index is defined as:</span><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> (AIIMS NOV 2016)</span></span></span></p>",
      "unique_key": "Q1401738",
      "question_audio": null,
      "question_video": null,
      "map_id": 13761925,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Answer: B. Weight in kilograms by cube of height in meters</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The Ponderal Index (PI) is a measure used to assess the leanness or corpulence of a person, especially newborns. It is calculated by dividing the weight in kilograms by the cube of the height in meters. This index helps to distinguish between symmetric and asymmetric growth retardation in infants. A PI of less than 2 indicates asymmetric growth retardation, while a PI of 2 or more suggests normal or symmetric growth retardation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. square root of height in feet by weight in grams</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> - This is not the correct formula for Ponderal Index.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Mid-upper arm circumference to head circumference ratio</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> - This is a different anthropometric measurement.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Head circumference to abdominal circumference ratio</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> - This is another anthropometric ratio used for different assessments.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The Ponderal Index is calculated as weight in kilograms divided by the cube of height in meters, used to assess growth patterns in infants.</span></span></span></p>",
      "correct_choice_id": 246698,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23238,
      "choices": [
        {
          "id": 92916,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 4</span></p>"
        },
        {
          "id": 92917,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 4</span></p>"
        },
        {
          "id": 92918,
          "text": "<p><span style=\"font-size:12.0pt;\">4</span></p>"
        },
        {
          "id": 92919,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 3, 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What are the recommended actions according to Neonatal Resuscitation guidelines for a baby born with meconium-stained amniotic fluid? (INICET MAY 2023)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">lntrapartum suction of nose and mouth before delivery of shoulder</span></li><li><span style=\"font-size:12.0pt;\">lntratracheal suction in case of non-vigorous baby</span></li><li><span style=\"font-size:12.0pt;\">Gentle suction of nose and mouth in case of vigorous baby</span></li><li><span style=\"font-size:12.0pt;\">PPV in case of non-vigorous baby after early steps</span></li></ol>",
      "unique_key": "Q4171913",
      "question_audio": null,
      "question_video": null,
      "map_id": 13761926,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 4</strong></span></p><p><br><span style=\"font-size:12.0pt;\">According to the Neonatal Resuscitation guidelines, the recommended actions for a newborn with meconium-stained amniotic fluid are as follows:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>4. For a non-vigorous baby&nbsp;</strong>(poor muscle tone, weak or absent respiratory effort, or heart rate &lt;100 bpm): The baby should receive <strong>positive pressure ventilation (PPV)</strong> following initial resuscitation steps. The current guidelines recommend PPV over routine intratracheal suctioning in non-vigorous infants because studies have shown that routine suctioning does not improve outcomes and may delay necessary resuscitation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. 1, 2, 3, 4:</strong> Intrapartum suction of the nose and mouth before delivery of the shoulders and routine intratracheal suctioning are no longer recommended in the current guidelines.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. 2, 4:</strong> While PPV is recommended for non-vigorous infants, routine intratracheal suctioning is not indicated.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. 1, 3, 4:</strong> Intrapartum suction is not recommended under the current guidelines.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><p><span style=\"font-size:12pt;\">For a newborn with meconium-stained amniotic fluid, PPV is administered if the baby is non-vigorous after the initial steps of resuscitation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/15/pedia-fmg-1-9.jpg\" alt=\"\" width=\"1000\" height=\"1538\"></span></p>",
      "correct_choice_id": 92918,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10272,
      "choices": [
        {
          "id": 41054,
          "text": "<p><span style=\"font-size:12.0pt;\">Juvenile myoclonic epilepsy</span></p>"
        },
        {
          "id": 41055,
          "text": "<p><span style=\"font-size:12.0pt;\">Atypical absence</span></p>"
        },
        {
          "id": 41056,
          "text": "<p><span style=\"font-size:12.0pt;\">Choreo-athetoid epilepsy</span></p>"
        },
        {
          "id": 41057,
          "text": "<p><span style=\"font-size:12.0pt;\">Centrotemporal spikes</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An adolescent girl complains of dropping objects from hands precipitated during morning hours and exams. There is no history of loss of consciousness. One of her cousins has been diagnosed with epilepsy. EEG was suggestive of epileptic spikes. What is the most probable diagnosis? (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q3330564",
      "question_audio": null,
      "question_video": null,
      "map_id": 13761927,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Juvenile myoclonic epilepsy</strong></span></p><p><br><span style=\"font-size:12.0pt;\">The clinical presentation described is consistent with <strong>Juvenile Myoclonic Epilepsy (JME)</strong>. JME is characterized by <strong>myoclonic jerks</strong>, which are sudden, brief, involuntary muscle contractions typically involving both arms. These jerks are most frequent in the morning, often leading to the dropping of objects, as described in this case. The patient maintains consciousness during these episodes, which is typical for JME.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Factors supporting the diagnosis:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Myoclonic jerks:&nbsp;</strong>The hallmark seizure type in JME, often occurring shortly after waking up in the morning.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Maintained consciousness:&nbsp;</strong>The patient remains aware during the myoclonic jerks.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Triggers:&nbsp;</strong>Seizures can be triggered by stimuli such as sleep deprivation, stress, and photic stimulation (e.g., flashing lights).</span></li><li><span style=\"font-size:12.0pt;\"><strong>Genetics:&nbsp;</strong>A mutation in the <strong>GABRA1</strong> gene is associated with JME.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Treatment:&nbsp;</strong>Sodium valproate is the drug of choice.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Prognosis:&nbsp;</strong>Generally good with appropriate treatment.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Atypical absence:</strong> Absence seizures are characterized by brief lapses in consciousness without motor symptoms like dropping objects. Atypical absences last longer than typical ones and have slower onset and resolution.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Choreo-athetoid epilepsy:</strong> This condition involves <strong>involuntary irregular movements</strong> of the face, head, trunk, and extremities, which does not align with the symptoms described in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Centrotemporal spikes:</strong> Benign Epilepsy with Centrotemporal Spikes (BECTS), also known as Rolandic epilepsy, involves brief stereotypical partial seizures, typically with facial and oropharyngeal involvement, not consistent with the symptomatology in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Juvenile Myoclonic Epilepsy (JME) is characterized by myoclonic jerks, typically occurring in the morning, with preserved consciousness and a good response to sodium valproate.</span></p>",
      "correct_choice_id": 41054,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 49029,
      "choices": [
        {
          "id": 195691,
          "text": "<p><span style=\"font-size:18px;\">Statement 1 and 3 are correct</span></p>"
        },
        {
          "id": 195692,
          "text": "<p><span style=\"font-size:18px;\">Statement 1 and 2 are correct</span></p>"
        },
        {
          "id": 195693,
          "text": "<p><span style=\"font-size:18px;\">Statement 1,2,3 are correct</span></p>"
        },
        {
          "id": 195694,
          "text": "<p><span style=\"font-size:18px;\">All are correct</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>Consider the following Statements? </strong><i><strong>[INICET NOV 2023]</strong></i></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\"><strong>Statement 1- Contemplation – A person who smokes is thinking of quitting smoking</strong></span></li><li><span style=\"font-size:18px;\"><strong>Statement 2- Precontemplation – A person is considering starting morning walks and its benefits to the health</strong></span></li><li><span style=\"font-size:18px;\"><strong>Statement 3- Maintenance phase/determination phase – A person quit smoking one year back and has not smoked since then</strong></span></li><li><span style=\"font-size:18px;\"><strong>Statement 4- Action phase – A person with obesity says he cant’s do anything as it runs deep in his family</strong></span></li></ul>",
      "unique_key": "Q7790312",
      "question_audio": null,
      "question_video": null,
      "map_id": 13761928,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (a)&nbsp;Statement 1 and 3 are correct</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>1. Contemplation</strong>: A person who smokes is thinking of quitting smoking. This statement correctly aligns with the contemplation phase where an individual acknowledges the problem and begins to think seriously about solving it soon but hasn’t committed to action yet.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>3. Maintenance phase/determination phase</strong>: A person quit smoking one year back and has not smoked since then. This is an accurate description of the maintenance phase, where the individual has made significant changes and is focused on maintaining these changes long-term. The use of \"determination phase\" here is non-standard; typically, it is just called \"maintenance.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>2. Precontemplation</strong>: A person is considering starting morning walks and its benefits to the health. This statement is incorrect for this phase. The precontemplation phase is characterized by a lack of awareness or denial of the problem, not considering changes. The correct description would be not considering the benefits or need for exercise.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>4</strong>. <strong>Action phase</strong>: A person with obesity says he can't do anything as it runs deep in his family. This statement incorrectly describes the action phase. The action phase involves active modification of behavior. This description instead suggests resignation or justification for inaction, which could fit the precontemplation or contemplation phase but is misaligned with the proactive nature of the action phase.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective </strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Behavior change – 6 stages –</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Precontemplation → Contemplation → Preparation/ Determination → Action/will power → Maintenance → Termination&nbsp;&nbsp;</span></p>",
      "correct_choice_id": 195691,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10309,
      "choices": [
        {
          "id": 41202,
          "text": "<p><span style=\"font-size:12.0pt;\">Drowsy child</span></p>"
        },
        {
          "id": 41203,
          "text": "<p><span style=\"font-size:12.0pt;\">Skin pinch retracts slowly</span></p>"
        },
        {
          "id": 41204,
          "text": "<p><span style=\"font-size:12.0pt;\">Thirsty child</span></p>"
        },
        {
          "id": 41205,
          "text": "<p><span style=\"font-size:12.0pt;\">Sunken fontanelle</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not a symptom of severe dehydration? </span><span style=\"font-size:10.5pt;\">(</span><span style=\"font-size:12.0pt;\">INICET MAY 2020)</span></p>",
      "unique_key": "Q6995644",
      "question_audio": null,
      "question_video": null,
      "map_id": 13761929,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Thirsty child.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Dehydration in children is classified based on clinical signs into mild (some dehydration) and severe dehydration. The symptoms of severe dehydration are crucial for determining the appropriate treatment and urgency of care.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">\"Thirsty child,\" is typically associated with some dehydration rather than severe dehydration. A thirsty child is likely still alert and responsive, seeking fluids, which suggests that dehydration is present but not yet severe.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Drowsy child</strong>: Indicates severe dehydration where the child’s mental status is altered, often due to inadequate perfusion to the brain.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Skin pinch retracts slowly</strong>: This is a reliable sign of severe dehydration and indicates significant fluid loss.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Sunken fontanelle</strong>: Especially in infants, a sunken fontanelle is a common and concerning sign of severe dehydration, indicating decreased intracranial pressure due to fluid loss.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A thirsty child indicates some dehydration, whereas signs like drowsiness, slow skin pinch retraction, and a sunken fontanelle are indicative of severe dehydration.</span></p><p>&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/17/28.jpg\" alt=\"\" width=\"1000\" height=\"1601\"></span></p>",
      "correct_choice_id": 41204,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9965,
      "choices": [
        {
          "id": 39826,
          "text": "<p><span style=\"font-size:12.0pt;\">Weight for age less than - 2SD</span></p>"
        },
        {
          "id": 39827,
          "text": "<p><span style=\"font-size:12.0pt;\">Weight for height less than + 2SD</span></p>"
        },
        {
          "id": 39828,
          "text": "<p><span style=\"font-size:12.0pt;\">Weight for age less than + 3SD</span></p>"
        },
        {
          "id": 39829,
          "text": "<p><span style=\"font-size:12.0pt;\">Weight for height less than - 3SD</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A child in your unit is diagnosed with severe acute malnutrition (SAM). According to the WHO criteria, SAM is defined best by: (NEET PG 2019)</span></p>",
      "unique_key": "Q3539633",
      "question_audio": null,
      "question_video": null,
      "map_id": 13761931,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Weight for height less than -3SD</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Severe acute malnutrition (SAM) is best defined as weight for height less than median minus -3SD</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Severe acute malnutrition (SAM) in children of ages 6 to 59 months is defined by the WHO as any of the following:</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/28/picture134.jpg\" alt=\"\" width=\"1000\" height=\"320\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Weight for age less than -2SD:&nbsp;</strong>This defines moderate acute malnutrition (MAM), not severe acute malnutrition (SAM).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Weight for height less than +2SD:&nbsp;</strong>This would indicate overnutrition or obesity, not malnutrition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Weight for age less than +3SD:&nbsp;</strong>This is not relevant to malnutrition and could indicate overnutrition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Severe acute malnutrition (SAM) is defined by the WHO as weight-for-height (or length) below -3 SD of the WHO Child Growth Standards, presence of bilateral pitting edema, or mid-upper arm circumference less than 11.5 cm.</span></p>",
      "correct_choice_id": 39829,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10337,
      "choices": [
        {
          "id": 41314,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 3, 4</span></p>"
        },
        {
          "id": 41315,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 4</span></p>"
        },
        {
          "id": 41316,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 3, 4</span></p>"
        },
        {
          "id": 41317,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Regarding urinary tract infection (UTI) in children, which of the following is true? (INICET MAY 2022)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Most common cause of UTI is Streptococcus pneumoniae.</span></li><li><span style=\"font-size:12.0pt;\">Bowel, bladder dysfunction increases the risk of recurrence.</span></li><li><span style=\"font-size:12.0pt;\">Cotrimoxazole is not given.</span></li><li><span style=\"font-size:12.0pt;\">Micturating cysto-urethrogram (MCU) is done in children with recurrence of UTI.</span></li></ol>",
      "unique_key": "Q6045989",
      "question_audio": null,
      "question_video": null,
      "map_id": 13761932,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 2, 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">It is true that bowel and bladder dysfunction increase the incidence of recurrence of UTI in children, and that children who experience a recurrence of UTI undergo a micturating cystourethrogram (MCU).&nbsp;</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-190052.jpg\" alt=\"\" width=\"1000\" height=\"595\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Understand that bowel and bladder dysfunction increases the risk of recurrent UTIs in children, and that MCU is performed in cases of recurrent UTI to assess for anatomical and functional abnormalities.</span></p>",
      "correct_choice_id": 41315,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10360,
      "choices": [
        {
          "id": 41406,
          "text": "<p><span style=\"font-size:12.0pt;\">10</span></p>"
        },
        {
          "id": 41407,
          "text": "<p><span style=\"font-size:12.0pt;\">7</span></p>"
        },
        {
          "id": 41408,
          "text": "<p><span style=\"font-size:12.0pt;\">8</span></p>"
        },
        {
          "id": 41409,
          "text": "<p><span style=\"font-size:12.0pt;\">9</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A preterm infant in the NICU was observed to have marked nasal flare, distinct xiphoid retractions, minimal intercostal retractions, and inspiratory lag with an audible grunt. What would be the Silverman Anderson score? &nbsp;? (AIIMS NOV 2018)</span></p>",
      "unique_key": "Q5605443",
      "question_audio": null,
      "question_video": null,
      "map_id": 13761953,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 8</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The <strong>Silverman-Anderson score</strong> is a clinical scoring system used to assess the degree of respiratory distress in neonates, particularly those with hyaline membrane disease (HMD) or other forms of respiratory distress syndrome (RDS). The score ranges from 0 to 10, with higher scores indicating more severe respiratory distress.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The score is based on five parameters, each scored from 0 to 2:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. Nasal Flaring:</strong></span></p><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">0: None</span></li><li><span style=\"font-size:12.0pt;\">1: Minimal</span></li><li><span style=\"font-size:12.0pt;\">2: Marked</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In this case, the infant has <strong>marked nasal flaring</strong> (score = 2).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>2. Xiphoid Retractions (Substernal Retractions):</strong></span></p><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">0: None</span></li><li><span style=\"font-size:12.0pt;\">1: Minimal</span></li><li><span style=\"font-size:12.0pt;\">2: Distinct</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The infant has <strong>distinct xiphoid retractions</strong> (score = 2).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>3. Intercostal Retractions:</strong></span></p><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">0: None</span></li><li><span style=\"font-size:12.0pt;\">1: Minimal</span></li><li><span style=\"font-size:12.0pt;\">2: Marked</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The infant has <strong>minimal intercostal retractions</strong> (score = 1).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>4. Chest Movement (Synchrony of Chest and Abdomen):</strong></span></p><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">0: Synchrony</span></li><li><span style=\"font-size:12.0pt;\">1: Lag on inspiration</span></li><li><span style=\"font-size:12.0pt;\">2: See-saw movement</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The infant has <strong>inspiratory lag</strong> (score = 1).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>5. Grunting:</strong></span></p><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">0: None</span></li><li><span style=\"font-size:12.0pt;\">1: Audible with stethoscope</span></li><li><span style=\"font-size:12.0pt;\">2: Audible without stethoscope</span></li></ul><p style=\"margin-left:48px;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\">The infant has an <strong>audible grunt</strong> (score = 2).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Calculation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Nasal Flaring: 2</span></li><li><span style=\"font-size:12.0pt;\">Xiphoid Retractions: 2</span></li><li><span style=\"font-size:12.0pt;\">Intercostal Retractions: 1</span></li><li><span style=\"font-size:12.0pt;\">Chest Movement: 1</span></li><li><span style=\"font-size:12.0pt;\">Grunting: 2</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Total Score = 2 + 2 + 1 + 1 + 2 = 8</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The correct <strong>Silverman-Anderson score</strong> for this infant would be <strong>8</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Silverman-Anderson score is used to assess the severity of respiratory distress in neonates, with a score of 8 indicating significant distress requiring close monitoring and possibly intervention.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/104.jpg\" alt=\"\" width=\"766\" height=\"448\"></span></p>",
      "correct_choice_id": 41408,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "CriteriaBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61859,
      "choices": [
        {
          "id": 246705,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cardiomegaly with pulmonary edema</span></span></span></p>"
        },
        {
          "id": 246706,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Boot-shaped heart due to right ventricular hypertrophy</span></span></span></p>"
        },
        {
          "id": 246707,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Egg-on-a-string appearance due to transposition of the great arteries</span></span></span></p>"
        },
        {
          "id": 246708,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Enlarged left atrium with double contour sign</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 4-year-old child presents with cyanosis and episodes of squatting during breathlessness. A chest X-ray is performed, revealing an abnormal heart shape. Based on the findings, which of the following best describes the chest X-ray image?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/19/picture1.jpg\" style=\"height:344px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q8334403",
      "question_audio": null,
      "question_video": null,
      "map_id": 13761954,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Answer: B) Boot-shaped heart due to right ventricular hypertrophy</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The chest X-ray image demonstrates a &quot;Coeur en sabot&quot; or boot-shaped heart, which is characteristic of Tetralogy of Fallot (TOF). This distinct appearance is due to right ventricular hypertrophy, which causes the cardiac apex to elevate, giving the heart a boot-like shape. TOF is a congenital heart defect that includes four key features: right ventricular hypertrophy, ventricular septal defect, pulmonary stenosis, and an overriding aorta.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Key Points from Explanation Hint:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&quot;Coeur en sabot&quot; (Boot-shaped Heart):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This term refers to the boot-like shape of the heart seen on X-ray due to elevation of the cardiac apex, resulting from right ventricular hypertrophy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Radiographic Features:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The hilar areas and lung fields appear relatively clear due to diminished pulmonary blood flow or the small size of the pulmonary arteries.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The aorta is typically large, contributing to the overall radiographic appearance.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Clinical Correlation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Children with TOF may present with cyanosis and characteristic symptoms such as squatting during hypoxic episodes, which helps to temporarily increase systemic vascular resistance and improve oxygenation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/19/picture2.jpg\" style=\"height:433px; width:600px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A) Cardiomegaly with pulmonary edema:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This finding typically shows an enlarged heart with fluid accumulation in the lungs, not seen in TOF.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">C) Egg-on-a-string appearance:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is characteristic of transposition of the great arteries, marked by a narrow superior mediastinum.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">D) Enlarged left atrium with double contour sign:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Commonly seen in conditions like mitral stenosis, which are unrelated to TOF.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The &quot;Coeur en sabot&quot; or boot-shaped heart seen on X-ray is characteristic of Tetralogy of Fallot, resulting from right ventricular hypertrophy. Recognizing this distinctive radiographic feature is essential for diagnosing TOF, a congenital heart condition requiring timely medical or surgical intervention to prevent severe complications.</span></span></span></p>",
      "correct_choice_id": 246706,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10416,
      "choices": [
        {
          "id": 41630,
          "text": "<p><span style=\"font-size:12.0pt;\">Ceftriaxone</span></p>"
        },
        {
          "id": 41631,
          "text": "<p><span style=\"font-size:12.0pt;\">Amoxicillin+ clavulanate</span></p>"
        },
        {
          "id": 41632,
          "text": "<p><span style=\"font-size:12.0pt;\">Vancomycin</span></p>"
        },
        {
          "id": 41633,
          "text": "<p><span style=\"font-size:12.0pt;\">Meropenem</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A child presents with complaints of fever, rash, body ache, and throat ache. He has a history of thorn prick injury a week back. What antibiotics would you give empirically to this child?</span> <span style=\"font-size:12.0pt;\">(INICET NOV 2022)</span></p>",
      "unique_key": "Q3187451",
      "question_audio": null,
      "question_video": null,
      "map_id": 13761955,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Amoxicilin +clavulanate</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The symptoms described in this case—fever, rash, sore throat, and body aches—following a thorn prick injury suggest the possibility of <strong>scarlet fever</strong> caused by Group A Streptococcus (GAS). Scarlet fever typically presents with a diffuse erythematous rash, which may be papular, along with other symptoms such as a sore throat, body aches, and the characteristic \"strawberry tongue.\"</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Key Points:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Scarlet Fever and GAS:&nbsp;</strong>Scarlet fever is most commonly caused by GAS and is characterized by the production of pyrogenic (erythrogenic) exotoxin, leading to the rash and other systemic symptoms.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Empirical Antibiotic Treatment:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\"><strong>Amoxicillin + Clavulanate</strong>: This combination is a first-line treatment for infections caused by GAS, particularly when there is a concern for beta-lactamase-producing bacteria. Clavulanate inhibits beta-lactamase enzymes, allowing amoxicillin to remain effective against the bacteria.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Penicillin or Amoxicillin&nbsp;</strong>alone is generally the treatment of choice for scarlet fever, but adding clavulanate broadens the spectrum to cover potential mixed infections.</span></li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Diagnostic Confirmation:&nbsp;</strong>While empirical treatment is initiated, a rapid antigen detection test or throat culture for Streptococcus should be performed to confirm the diagnosis of GAS infection.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Ceftriaxone:&nbsp;</strong>Ceftriaxone is a broad-spectrum antibiotic that is typically reserved for more severe infections requiring hospitalization. It is not the first choice for uncomplicated scarlet fever.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Vancomycin. and Option D. Meropenem:&nbsp;</strong>These are higher-tier antibiotics reserved for severe or resistant infections, often guided by culture and sensitivity results. They are not typically used as first-line treatment in cases of suspected scarlet fever or mild GAS infections.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For a child presenting with symptoms suggestive of scarlet fever following a thorn prick injury, empirical antibiotic treatment with amoxicillin + clavulanate is appropriate while awaiting diagnostic confirmation of Group A Streptococcus infection.</span></p>",
      "correct_choice_id": 41631,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10129,
      "choices": [
        {
          "id": 40482,
          "text": "<p><span style=\"font-size:12.0pt;\">Nephrotic syndrome</span></p>"
        },
        {
          "id": 40483,
          "text": "<p><span style=\"font-size:12.0pt;\">Nephritic syndrome</span></p>"
        },
        {
          "id": 40484,
          "text": "<p><span style=\"font-size:12.0pt;\">Goodpasture's disease</span></p>"
        },
        {
          "id": 40485,
          "text": "<p><span style=\"font-size:12.0pt;\">IgA nephropathy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A child presents with generalized edema and was found to have hypercholesterolemia. Urinalysis shows protein 3+ and fat bodies. What is the likely diagnosis? (NEET PG 2021)</span></p>",
      "unique_key": "Q2076568",
      "question_audio": null,
      "question_video": null,
      "map_id": 13761956,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Nephrotic syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical presentation of a child with generalized edema, hyperlipidemia, massive proteinuria, and fat bodies is highly suggestive of nephrotic syndrome, which is a glomerular disease characterized by heavy proteinuria. The diagnosis of nephrotic syndrome is based on the triad of hypoalbuminemia (≤2.5 g/dL), edema, and hyperlipidemia (cholesterol &gt;200 mg/dL) in addition to proteinuria &gt;3.5 g/24 hr or a urine protein:creatinine ratio &gt;2.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Causes of Nephrotic Syndrome:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/28/picture153.jpg\" alt=\"\" width=\"1000\" height=\"282\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Nephritic syndrome</strong>: Nephritic syndrome classically presents with tea- or cola-colored urine (hematuria), edema, hypertension, and oliguria.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Conditions which present as glomerulonephritis:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Postinfectious glomerulonephritis</span></li><li><span style=\"font-size:12.0pt;\">IgA nephropathy (Option D)</span></li><li><span style=\"font-size:12.0pt;\">Membranoproliferative glomerulonephritis</span></li><li><span style=\"font-size:12.0pt;\">Henoch-Schönlein purpura (HSP) nephritis</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Goodpasture syndrome</strong>: Goodpasture syndrome also referred to as anti-glomerular basement membrane (anti-GBM) disease, is an autoimmune disease that affects both the kidneys and lungs by the formation of autoantibodies that attack their basement membranes. Plasmapheresis is recommended in patients with pauci-immune crescentic GN and Goodpasture syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. IgA nephropathy</strong>: IgA nephropathy, also known as Berger's disease, is a kidney disorder that occurs when immunoglobulin A (IgA), a protein that helps the body fight infections, settles in the kidneys. This can cause inflammation that, over time, can affect the kidneys' ability to filter waste from the blood. IgA nephropathy is one of the most common glomerulonephritis, a type of kidney disease that affects the glomeruli, the tiny filters within the kidneys that filter waste and excess fluids from the blood.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Some common features of IgA nephropathy include:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Hematuria</strong>: The most common symptom is the presence of blood in the urine (hematuria), which can make the urine appear pink or cola-colored.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Proteinuria</strong>: Protein in the urine (proteinuria) may also occur but is typically less significant than in other kidney diseases.</span></li><li><span style=\"font-size:12.0pt;\"><strong>High Blood Pressure</strong>: Some individuals may develop high blood pressure.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Nephrotic syndrome is characterized by generalized edema, hyperlipidemia, massive proteinuria, and fat bodies in urinalysis</span></p>",
      "correct_choice_id": 40482,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10315,
      "choices": [
        {
          "id": 41226,
          "text": "<p><span style=\"font-size:12.0pt;\">Bacterial meningitis with sepsis</span></p>"
        },
        {
          "id": 41227,
          "text": "<p><span style=\"font-size:12.0pt;\">Coxsackie viral meningitis and Hand Foot Mouth disease</span></p>"
        },
        {
          "id": 41228,
          "text": "<p><span style=\"font-size:12.0pt;\">Herpes simplex gingivostomatitis and meningoencephalitis</span></p>"
        },
        {
          "id": 41229,
          "text": "<p><span style=\"font-size:12.0pt;\">Tuberculous meningitis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A child presents with fever and vesicular lesions on the upper limb and the lower limb. Neck stiffness was present. Similar lesions were present on the palms, soles, and oral cavity. CSF analysis revealed normal glucose levels and elevated lymphocytes and protein. What is the most likely diagnosis? </span><span style=\"font-size:10.5pt;\">(</span><span style=\"font-size:12.0pt;\">INICET MAY 2021)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/25.jpg\" alt=\"\" width=\"300\" height=\"300\"></p>",
      "unique_key": "Q5009694",
      "question_audio": null,
      "question_video": null,
      "map_id": 13761957,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Coxsackie viral meningitis and Hand Foot Mouth disease</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical vignette and images provided suggest HFMD meningitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The presence of vesicular lesions on the palms, soles, and oral cavity, as well as images of the lesions, suggest Hand-foot-and-mouth disease (HFMD). The presence of neck stiffness, as well as CSF with normal glucose levels, elevated lymphocytes, and protein levels, suggests viral meningitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Therefore the best answer is - Coxsackie viral meningitis and Hand Foot Mouth disease</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Hand-foot-and-mouth disease:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Causes:</u></strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Hand-foot-and-mouth disease (HFMD) is commonly caused by coxsackievirus A16 which is a subgroup of enteroviruses.</span></li><li><span style=\"font-size:12.0pt;\">In large outbreaks, other enteroviruses like enterovirus71, coxsackie A viruses 5,6,7,9, 10 and coxsackie B virus 2 and 5 may also cause HFMD.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Clinical features</u>:</strong></span><span style=\"font-size:10.5pt;\"> </span><span style=\"font-size:12.0pt;\">HFMD is often a minor condition.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The tongue, posterior pharynx, buccal mucosa, palate, lips, etc. may all have vesicular lesions.</span></li><li><span style=\"font-size:12.0pt;\">Lesions that are maculopapular, vesicular, or pustular may appear on the hands, fingers, buttocks, or groin.</span></li><li><span style=\"font-size:12.0pt;\">Compared to the feet, lesions are more frequently found on the hands.</span></li><li><span style=\"font-size:12.0pt;\">These vesicles disappear within a week.</span></li><li><span style=\"font-size:12.0pt;\">Enterovirus 71 infections are more serious and are linked to cardiovascular and neurological symptoms.</span></li><li><span style=\"font-size:12.0pt;\">Complications from coxsackievirus A16 infections might occasionally include shock, encephalitis, acute flaccid paralysis, and myocarditis.</span></li><li><span style=\"font-size:12.0pt;\">A severe variant of HFMD called atypical HFMD is caused by coxsackievirus A6.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Diagnosis:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">HFMD is usually diagnosed clinically by the characteristic lesions.</span></li><li><span style=\"font-size:12.0pt;\">Viral culture can be done to confirm the presence of enterovirus. Blood, CSF, urine, and mucosal swabs can be cultured.</span></li><li><span style=\"font-size:12.0pt;\">RT-PCR testing to detect the viral genome is more sensitive and specific.</span></li><li><span style=\"font-size:12.0pt;\">PCR testing of CSF in children with meningitis is frequently positive even when the cultures are negative.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Treatment:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">No specific antiviral agent is proven to be effective against enteroviruses. Supportive care is the mainstay of treatment.</span></li><li><span style=\"font-size:12.0pt;\">Milrinone is suggested as an effective agent for enterovirus 71 cardiopulmonary disease.</span></li><li><span style=\"font-size:12.0pt;\">Immunoglobulins have been used to manage severe cases but with varying outcomes.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Bacterial meningitis with sepsis:</strong> Bacterial meningitis with sepsis is not a likely differential diagnosis for vesicular lesions with this distribution. HSV encephalitis manifests with typical findings of injury to the frontal or parietal cortex or limbic system, including anosmia, memory loss, focal seizures, expressive aphasia, and peculiar behaviour.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Herpes simplex gingivostomatitis and meningoencephalitis:</strong> Despite having vesicular lesions, meningoencephalitis and herpes simplex gingivostomatitis show differently clinically. High-grade fever, rapid onset of excruciating mouth pain, and saliva dribbling are the symptoms of HSV gingivostomatitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Tuberculous meningitis:</strong> Tuberculous meningitis is improbable given the absence of a history of exposure to TB. CSF results in bacterial meningitis often include reduced glucose and raised neutrophils and protein levels. In most cases, CSF results in tuberculous meningitis demonstrate decreased glucose and high amount</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The majority of the time, CSF results in tuberculous meningitis demonstrate decreased glucose levels, increased lymphocytes, and protein levels.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Other possible differentials for vesicular lesions include hand-foot-and-mouth disease, varicella (chickenpox), and herpangina.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Coxsackie viral infection can cause Hand-foot-and-mouth disease with associated viral meningitis, characterized by vesicular lesions on the palms, soles, and oral cavity, along with normal glucose and elevated lymphocytes in CSF.</span></p>",
      "correct_choice_id": 41227,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10294,
      "choices": [
        {
          "id": 41142,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Spironolactone</span></span></span></p>"
        },
        {
          "id": 41143,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Potassium binding resins</span></span></span></p>"
        },
        {
          "id": 41144,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hydrocortisone</span></span></span></p>"
        },
        {
          "id": 41145,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Broad spectrum antibiotics</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 3-week neonate presents with ambiguous genitalia with Na+ - 127, K+ - 6 meq with a BP of 50/22 mm Hg. Along with IV fluids, what specific management is done? (AIIMS MAY 2019)</span></span></p>",
      "unique_key": "Q3903658",
      "question_audio": null,
      "question_video": null,
      "map_id": 13761958,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Hydrocortisone</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The neonate in this case presents with ambiguous genitalia, hyponatremia (Na+ 127 mEq/L), hyperkalemia (K+ 6 mEq/L), and hypotension (BP 50/22 mm Hg). These findings are suggestive of congenital adrenal hyperplasia (CAH), most likely due to 21-hydroxylase deficiency. CAH is an autosomal recessive disorder characterized by a deficiency in cortisol production, leading to an overproduction of androgens and a deficiency in aldosterone, which causes salt-wasting and hyperkalemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The treatment of choice in this situation is hydrocortisone, which replaces the deficient glucocorticoids. Hydrocortisone will help manage the adrenal insufficiency by increasing cortisol levels, thereby normalizing blood pressure, glucose levels, and reducing the overproduction of androgens. In addition to hydrocortisone, mineralocorticoid replacement with fludrocortisone may also be required to address the salt-wasting.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Spironolactone</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is a potassium-sparing diuretic and aldosterone antagonist. It is not appropriate in this scenario as it would exacerbate hyperkalemia and does not address the underlying cortisol deficiency.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Potassium binding resins</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: These are used to treat hyperkalemia by promoting the excretion of potassium in the stool. While they may reduce potassium levels, they do not address the underlying cause of the hyperkalemia, which is the deficiency in cortisol and aldosterone.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Broad spectrum antibiotics</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:&nbsp;</span></span></span><span style=\"font-family:Calibri,sans-serif; font-size:12pt\">Antibiotics are used to treat infections and are not relevant in managing CAH unless the patient has a concurrent infection.</span></p>\r\n\r\n<h3>&nbsp;</h3>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hydrocortisone is the first-line treatment for congenital adrenal hyperplasia (CAH) with 21-hydroxylase deficiency, which presents with ambiguous genitalia, hyponatremia, hyperkalemia, and hypotension in neonates.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/17/screenshot-2023-11-17-114802.png\" style=\"height:790px; width:805px\" /></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/17/02.jpg\" style=\"height:501px; width:700px\" /></span></strong></span></span></p>",
      "correct_choice_id": 41144,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10409,
      "choices": [
        {
          "id": 41602,
          "text": "<p><span style=\"font-size:12.0pt;\">12 - 18 months</span></p>"
        },
        {
          "id": 41603,
          "text": "<p><span style=\"font-size:12.0pt;\">20 - 24 months</span></p>"
        },
        {
          "id": 41604,
          "text": "<p><span style=\"font-size:12.0pt;\">32 - 36 months</span></p>"
        },
        {
          "id": 41605,
          "text": "<p><span style=\"font-size:12.0pt;\">40 - 48 months</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">At what age does a child attain half-height of the adult height?</span><span style=\"font-size:10.5pt;\"> </span><span style=\"font-size:12.0pt;\">(INICET NOV 2021)</span></p>",
      "unique_key": "Q7129764",
      "question_audio": null,
      "question_video": null,
      "map_id": 13761959,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 20-24 months</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Children attain half of their adult height by the age of 20-24 months.</span></li><li><span style=\"font-size:12.0pt;\">For children under 2 years of age, length is measured with the help of&nbsp; an infantometer or rigid measuring table. The infant's head is held firmly against a fixed upright headboard, legs are straightened, and feet are at right angles to legs with toes pointing upwards. The length of the baby is measured from a scale set in the measuring table.</span></li><li><span style=\"font-size:12.0pt;\">Measuring the length of a child lying on a mattress or using cloth tapes is inaccurate and not recommended.</span></li><li><span style=\"font-size:12.0pt;\">Height is measured by asking the child to stand upright with heels, buttocks, shoulder blades, and back of the head in contact with a vertical surface such as a wall, height measuring rod, or a stadiometer. The child should look directly forward, and the headpiece is kept firmly over the head to compress the hair.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The growth and development of a child between the age of 18 - 24 months can be classified as,</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/27/picture121.jpg\" alt=\"\" width=\"1000\" height=\"508\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Children typically attain half of their adult height by 20-24 months, a critical milestone in early childhood growth and development.</span></p>",
      "correct_choice_id": 41603,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10380,
      "choices": [
        {
          "id": 41486,
          "text": "<p><span style=\"font-size:12.0pt;\">Alport syndrome</span></p>"
        },
        {
          "id": 41487,
          "text": "<p><span style=\"font-size:12.0pt;\">Goodpasture syndrome</span></p>"
        },
        {
          "id": 41488,
          "text": "<p><span style=\"font-size:12.0pt;\">IgA nephropathy</span></p>"
        },
        {
          "id": 41489,
          "text": "<p><span style=\"font-size:12.0pt;\">PSGN</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An 8-year-old boy with sensorineural hearing loss and eye defects presents to the OPD with hematuria. His renal biopsy on light microscopy was normal. Family history reveals the maternal uncle had Gr 5 CKD and is undergoing dialysis. Which of the following would be the probable diagnosis? (AIIMS NOV 2019)</span></p>",
      "unique_key": "Q8836377",
      "question_audio": null,
      "question_video": null,
      "map_id": 13761960,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Alport syndrome.</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/17/screenshot-2024-09-17-141312.png\" alt=\"\" width=\"1000\" height=\"549\"></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/108.jpg\" alt=\"\" width=\"491\" height=\"366\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A, Alport syndrome (EM), Note the presence of both the characteristic “basket- weave” change (asterisks) and thinning of the GBM (arrows).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Goodpasture syndrome</strong>: Goodpasture syndrome is an immune-mediated disease characterised by antibodies against the alpha-3 chain of GBM type IV collagen; it is not hereditary, and light microscopy reveals extracapillary growth with crescents and necrosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong></span><span style=\"font-size:14px;\"><strong>&nbsp;</strong></span><span style=\"font-size:12.0pt;\"><strong>IgA nephropathy</strong></span><span style=\"font-size:12pt;\">: In IgA nephropathy, light microscopy would demonstrate focal mesangial proliferative glomerulonephritis and mesangial widening.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.</strong></span><span style=\"font-size:10.5pt;\"><strong> </strong></span><span style=\"font-size:12.0pt;\"><strong>PSGN</strong>:&nbsp; In PSGN, light microscopy would reveal diffuse endocapillary proliferation with concomitant leukocytic infiltration in LM.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Alport syndrome is a genetic disorder characterized by hematuria, sensorineural hearing loss, and ocular abnormalities, with characteristic findings on electron microscopy, including a \"basket-weave\" appearance of the glomerular basement membrane.</span></p>",
      "correct_choice_id": 41486,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10110,
      "choices": [
        {
          "id": 40406,
          "text": "<p><span style=\"font-size:12.0pt;\">Tetralogy of Fallot</span></p>"
        },
        {
          "id": 40407,
          "text": "<p><span style=\"font-size:12.0pt;\">Atrial septal defect</span></p>"
        },
        {
          "id": 40408,
          "text": "<p><span style=\"font-size:12.0pt;\">Ventricular septal defect</span></p>"
        },
        {
          "id": 40409,
          "text": "<p><span style=\"font-size:12.0pt;\">Ebstein's anomaly</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The given chest X-ray is suggestive of: (NEET PG 2020)</span></p><p>&nbsp;</p><p><span style=\"font-size:10.5pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/picture3_POGu9gC.jpg\" alt=\"\" width=\"250\" height=\"295\"></span></p>",
      "unique_key": "Q8310404",
      "question_audio": null,
      "question_video": null,
      "map_id": 13761961,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Tetralogy of Fallot</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given chest X-ray is suggestive of the Tetralogy of Fallot. The boot-shaped cardiac silhouette is seen due to the right ventricular hypertrophy and upward shift of the cardiac apex.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Tetralogy of Fallot is a congenital heart defect that affects the structure of the heart, specifically the four major components of the heart: the pulmonary valve, the right ventricle, the ventricular septum, and the aortic valve. It is a combination of four heart defects, which are:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Pulmonary stenosis - narrowing of the pulmonary valve, which reduces blood flow to the lungs.</span></li><li><span style=\"font-size:12.0pt;\">Ventricular septal defect - a hole in the wall that separates the right and left ventricles, which allows oxygen-poor and oxygen-rich blood to mix.</span></li><li><span style=\"font-size:12.0pt;\">Overriding aorta - the aorta is located over the ventricular septal defect, which allows blood to flow from both the left and right ventricles to the body.</span></li><li><span style=\"font-size:12.0pt;\">Right ventricular hypertrophy - thickening of the right ventricle due to increased workload, which can lead to heart failure.</span></li></ol><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/17/pedia-fmg-1-2.jpg\" alt=\"\" width=\"400\" height=\"274\"></p><p>&nbsp;</p><p><span style=\"font-size:10.5pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/picture5_Uzc0cBu.jpg\" alt=\"\" width=\"400\" height=\"259\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Atrial septal defect (ASD):&nbsp;</strong>This condition typically shows plethoric lung fields and a wide, fixed split of S2. The X-ray findings in the question do not correlate with ASD, as it does not present with a boot-shaped heart.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Ventricular septal defect (VSD):&nbsp;</strong>VSD usually shows wide, variable splitting of S2 and plethoric lung fields due to increased pulmonary blood flow. The X-ray findings described do not match VSD.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Ebstein's anomaly:&nbsp;</strong>This condition often presents with a box-shaped heart due to maternal lithium intake during pregnancy. The X-ray findings in the question do not show a box-shaped heart, thus not fitting Ebstein's anomaly.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The boot-shaped heart on a chest X-ray is indicative of Tetralogy of Fallot (TOF), a congenital heart defect characterized by pulmonary stenosis, ventricular septal defect, overriding aorta, and right ventricular hypertrophy.</span></p>",
      "correct_choice_id": 40406,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9947,
      "choices": [
        {
          "id": 39754,
          "text": "<p><span style=\"font-size:12pt;\">Melasma</span></p>"
        },
        {
          "id": 39755,
          "text": "<p><span style=\"font-size:12pt;\">Fixed drug eruption (FDE)</span></p>"
        },
        {
          "id": 39756,
          "text": "<p><span style=\"font-size:12pt;\">Dengue</span></p>"
        },
        {
          "id": 39757,
          "text": "<p><span style=\"font-size:12pt;\">Chikungunya</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">The patient presented with symptoms of fever, body ache, and joint pain, and was treated with NSAIDs. Subsequently, a few days later, the patient developed brownish pigmentation on the nose. What is the probable diagnosis? (</span>AIIMS Nov 2018)</p>",
      "unique_key": "Q2809891",
      "question_audio": null,
      "question_video": null,
      "map_id": 13761962,
      "difficulty_level": "beginner",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Chikungunya</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The patient's medical history is indicative of a potential diagnosis of <strong>Chikungunya (CKG)</strong> infection.</span></li><li><span style=\"font-size:12pt;\">Chikungunya is a <strong>mosquito-borne viral</strong> illness presenting with <strong>fever, joint pain,</strong> and potential rash.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/27/picture3_mqsfsVJ.png\" alt=\"\" width=\"400\" height=\"302\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Fig</strong>. Nose pigmentation</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>IMAGE DEPICTING CHIK SIGN</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">It can cause skin <strong>hyperpigmentation</strong>, especially on the <strong>nose and cheeks</strong>, known as the <strong>\"Chik sign.\"</strong></span></li><li><span style=\"font-size:12pt;\">The \"Chik sign\" is <strong>distinctive to Chikungunya</strong> and is not usually seen with other viral infections.</span></li><li><span style=\"font-size:12pt;\">The <strong>nose</strong> pigmentation may last <strong>three to six months</strong> post-infection, aiding in <strong>clinical and retrospective diagnosis</strong>.</span></li><li><span style=\"font-size:12pt;\">This pigmentation pattern serves as a <strong>clinical marker</strong> for Chikungunya infection.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Melasma</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Typically presents as <strong>symmetric brown</strong> patches on the face, especially the <strong>cheeks, bridge of the nose, forehead, chin, and above the upper lip</strong> as shown in the image below.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/27/picture26.jpg\" alt=\"\" width=\"400\" height=\"268\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">It is often triggered by <strong>sun exposure</strong> or <strong>hormonal changes</strong>, such as <strong>pregnancy</strong> or use of <strong>oral contraceptives</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Fixed drug eruption (FDE)</strong>:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">It is a type of <strong>allergic</strong> reaction to <strong>medications</strong>. It presents as well-demarcated, round, or oval patches of <strong>redness a</strong>nd s<strong>welling</strong> that can later become <strong>brown</strong>.</span></li><li><span style=\"font-size:12pt;\">However, FDEs are typically r<strong>ecurrent</strong> in the <strong>same location</strong> when the offending <strong>drug is taken again</strong>, and the presentation isn't specifically associated with the symptoms described.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Dengue</strong>:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">While dengue fever is also a <strong>mosquito-borne</strong> viral infection leading to symptoms like <strong>fever, headache, and joint pains</strong>, it does not typically result in brownish pigmentation on the nose.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In the context of <strong>fever, body ache, and joint pain</strong>, followed by the development of <strong>brownish pigmentation</strong> on the nose, <strong>Chikungunya</strong> is the probable diagnosis, as it can present with persistent <strong>joint pain</strong> and <strong>hyperpigmentation,</strong> particularly in regions where the virus is <strong>endemic.</strong></span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Rook's Textbook of Dermatology - 9th Edition - Volume I, Chapter 118, Page no 118.11</strong></span></p><p><span style=\"font-size:12pt;\"><strong>HARRISONS PRINCIPLES OF INTERNAL MEDICINE 21<sup>ST</sup> EDITION PAGE 141-142, 1633</strong></span></p>",
      "correct_choice_id": 39757,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10422,
      "choices": [
        {
          "id": 41654,
          "text": "<p><span style=\"font-size:12.0pt;\">Insulin</span></p>"
        },
        {
          "id": 41655,
          "text": "<p><span style=\"font-size:12.0pt;\">Growth hormone</span></p>"
        },
        {
          "id": 41656,
          "text": "<p><span style=\"font-size:12.0pt;\">Thyroxine</span></p>"
        },
        {
          "id": 41657,
          "text": "<p><span style=\"font-size:12.0pt;\">Glucocorticoids</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The hormone that does not play a role in the growth of the fetus is: (INICET NOV 2022)</span></p>",
      "unique_key": "Q6148651",
      "question_audio": null,
      "question_video": null,
      "map_id": 13761963,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Growth hormone.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Fetal growth&nbsp;</strong>is a complex process regulated by various hormones, but <strong>growth hormone</strong> does not play a significant role in this process during fetal life. The primary hormones involved in fetal growth include insulin, thyroxine, and glucocorticoids.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Key Points:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Insulin:&nbsp;</strong>Insulin is crucial for fetal growth, especially during the third trimester. It plays a key role in promoting the storage of nutrients and the growth of fetal tissues, particularly adipose tissue and muscle.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Thyroxine:&nbsp;</strong>Fetal production of thyroxine begins around the 12th week of gestation. Thyroxine is vital for the development of the central nervous system and overall growth and differentiation of tissues.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Glucocorticoids:&nbsp;</strong>Glucocorticoids are essential towards the end of gestation, particularly for the maturation of organs such as the lungs, liver, and gastrointestinal tract. They help prepare the fetus for life outside the womb by stimulating the production of surfactant in the lungs and facilitating the maturation of other critical systems.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Growth Hormone:&nbsp;</strong>Unlike in postnatal life, where growth hormone is a key regulator of growth, its role in fetal growth is minimal. Fetal growth is largely driven by insulin and other growth factors rather than growth hormone.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Insulin and Option C. Thyroxine:&nbsp;</strong>Both are crucial for fetal growth, regulating tissue growth and differentiation, especially in the later stages of pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Glucocorticoids:&nbsp;</strong>These hormones are essential for the maturation of fetal organs before birth, particularly in the liver, lungs, and gastrointestinal tract.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Growth hormone does not play a significant role in fetal growth, which is primarily regulated by insulin, thyroxine, and glucocorticoids.</span></p>",
      "correct_choice_id": 41655,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61858,
      "choices": [
        {
          "id": 246701,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Intraosseous</span></span></span></p>"
        },
        {
          "id": 246702,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Through umbilical vein</span></span></span></p>"
        },
        {
          "id": 246703,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Through peripheral vein</span></span></span></p>"
        },
        {
          "id": 246704,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Through umbilical artery</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">What is the ideal route of drug delivery during neonatal resuscitation?</span><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> (AIIMS NOV 2016)</span></span></span></p>",
      "unique_key": "Q7608771",
      "question_audio": null,
      "question_video": null,
      "map_id": 13761964,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Correct Answer: B. Through umbilical vein</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The umbilical vein is the preferred route for drug delivery during neonatal resuscitation. This method is favored because veins in the scalp or extremities can be difficult to access in emergency situations. The umbilical vein provides a reliable and quick access point for administering medications and fluids.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A. Intraosseous</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> - Typically used in older children and adults when intravenous access is not possible, but not preferred in neonates during resuscitation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">C. Through peripheral vein</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> - Peripheral veins are harder to access quickly in a resuscitation scenario involving neonates.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">D. Through umbilical artery</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> - This is not used for drug delivery; it is primarily used for blood gas analysis and monitoring.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">During neonatal resuscitation, the umbilical vein is the preferred route for drug delivery due to its quick and reliable access.</span></span></span></p>",
      "correct_choice_id": 246702,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6480,
      "choices": [
        {
          "id": 25889,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Meropenem</span></span></span></p>"
        },
        {
          "id": 25890,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Imipenem</span></span></span></p>"
        },
        {
          "id": 25891,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Etrapenem</span></span></span></p>"
        },
        {
          "id": 25892,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Doripenem</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following Carbapenems has highest risk of causing seizures?</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (NEET PG 2019)</span></span></p>",
      "unique_key": "Q6549636",
      "question_audio": null,
      "question_video": null,
      "map_id": 13762165,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Imipenem</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Imipenem is a Carbapenem that has a maximum risk of causing seizures , hence it is contraindicated in epileptic patients.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Imipenem excretion is primarily renal, so dosage adjustments are required to avoid seizures in patients with renal failure.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Meropenem:&nbsp;</span></strong></span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Meropenem has a lower risk of inducing seizures compared to imipenem, making it a safer alternative for patients with a history of seizures or those at higher risk.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Ertapenem:&nbsp;</span></strong></span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ertapenem is also associated with a lower risk of seizures compared to imipenem and is used in various infections but is less effective against Pseudomonas aeruginosa and Acinetobacter species.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Doripenem:&nbsp;</span></strong></span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Doripenem, like meropenem and ertapenem, has a lower seizure risk compared to imipenem and is used in treating complex bacterial infections.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Imipenem carries the highest risk of inducing seizures among the carbapenem antibiotics, particularly in patients with renal impairment or a history of epilepsy. Proper dosage adjustments and careful monitoring are essential to minimize this risk.</span></span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 25890,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6080,
      "choices": [
        {
          "id": 24289,
          "text": "<p><span style=\"font-size:12pt;\">Squamous cell carcinoma</span></p>"
        },
        {
          "id": 24290,
          "text": "<p><span style=\"font-size:12pt;\">Clear cell adenocarcinoma</span></p>"
        },
        {
          "id": 24291,
          "text": "<p><span style=\"font-size:12pt;\">Adenocarcinoma</span></p>"
        },
        {
          "id": 24292,
          "text": "<p><span style=\"font-size:12pt;\">Sarcoma botryoides</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The daughter of a woman who received diethylstilbestrol during her pregnancy is at higher risk for?&nbsp;</span>(INICET NOV 2022)</p>",
      "unique_key": "Q9258403",
      "question_audio": null,
      "question_video": null,
      "map_id": 13762166,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Clear cell adenocarcinoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Diethylstilbestrol (DES)</strong> is a synthetic estrogen that was previously prescribed to pregnant women to prevent miscarriages and other pregnancy complications. It was later discovered to be a teratogen and is no longer used.</span></li><li><span style=\"font-size:12pt;\">Exposure to DES in utero is known to cause the following conditions:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\"><strong>In girls</strong>:</span><ul style=\"list-style-type:square;\"><li><span style=\"font-size:12pt;\">T-shaped uterus</span></li><li><span style=\"font-size:12pt;\">Cockscomb cervix</span></li><li><span style=\"font-size:12pt;\">Vaginal and cervical clear cell adenocarcinoma</span></li></ul></li><li><span style=\"font-size:12pt;\"><strong>In boys</strong>:</span><ul style=\"list-style-type:square;\"><li><span style=\"font-size:12pt;\">Micropenis</span></li><li><span style=\"font-size:12pt;\">Hypospadias</span></li><li><span style=\"font-size:12pt;\">Undescended testes</span></li></ul></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Squamous cell carcinoma</strong>: Squamous cell carcinoma is the most common type of cervical cancer. It arises from the ectocervix, at the squamocolumnar junction. This type of cancer is not specifically associated with DES exposure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Adenocarcinoma</strong>: Adenocarcinoma arises from the endocervix and is not specifically linked to DES exposure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Sarcoma botryoides</strong>: Sarcoma botryoides is a type of rhabdomyosarcoma that arises from the cervix. It presents as a pinkish polypoidal growth filling up the vagina completely and causes blood-tinged watery discharge. It is not associated with DES exposure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">DES exposure in utero is specifically associated with an increased risk of clear cell adenocarcinoma of the vagina and cervix.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: William’s textbook of obstetrics 24<sup>th</sup> edition pg42</strong></span></p>",
      "correct_choice_id": 24290,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4317,
      "choices": [
        {
          "id": 17245,
          "text": "<p><span style=\"font-size:12.0pt;\">1 - 2 - 3 - 4 - 5</span></p>"
        },
        {
          "id": 17246,
          "text": "<p><span style=\"font-size:12.0pt;\">5 - 4 - 3 - 2 - 1</span></p>"
        },
        {
          "id": 17247,
          "text": "<p><span style=\"font-size:12.0pt;\">2 - 1 - 3 - 4 - 5</span></p>"
        },
        {
          "id": 17248,
          "text": "<p><span style=\"font-size:12.0pt;\">3 - 4 - 5 - 1 - 2</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Arrange the following in the sequence of auditory pathway: (</span>INICET Nov 2020)</p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Cochlear nucleus</span></li><li><span style=\"font-size:12.0pt;\">Spiral ganglion</span></li><li><span style=\"font-size:12.0pt;\">Superior olivary nucleus</span></li><li><span style=\"font-size:12.0pt;\">Inferior colliculus</span></li><li><span style=\"font-size:12.0pt;\">Medial geniculate body</span></li></ol>",
      "unique_key": "Q9628674",
      "question_audio": null,
      "question_video": null,
      "map_id": 13762167,
      "difficulty_level": "beginner",
      "subjects_id": [
        9
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 2 - 1 - 3 - 4 - 5</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The auditory pathway is the sequence of neural structures that sound information travels through from the ear to the brain for processing. The correct sequence from the initial sensory input at the ear to the higher centers of the brain is as follows:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>2. Spiral ganglion :</strong> Contains the cell bodies of the auditory nerve fibers. These neurons receive mechanical sound vibrations converted into electrical signals by the hair cells of the cochlea.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. Cochlear nucleus :</strong> The first brainstem nucleus where auditory nerve fibers synapse. This nucleus begins the central processing of auditory information.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>3. Superior olivary nucleus :</strong> Receives inputs from both cochlear nuclei and is involved in binaural cues for sound localization.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>4. Inferior colliculus :</strong> A midbrain nucleus that acts as a major relay and integration point for auditory information.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>5. Medial geniculate body :</strong> Part of the thalamus that acts as the final relay station for auditory information being sent to the auditory cortex in the brain.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The correct sequence of structures involved in the auditory pathway from the periphery to the center is (E COLI MA).&nbsp;</span><ol><li><span style=\"font-size:12.0pt;\">Eighth (Vestibulocochlear) nerve</span></li><li><span style=\"font-size:12.0pt;\">Cochlear Nucleus</span></li><li><span style=\"font-size:12.0pt;\">Superior Olivary nucleus</span></li><li><span style=\"font-size:12.0pt;\">Lateral lemniscus</span></li><li><span style=\"font-size:12.0pt;\">Inferior colliculus</span></li><li><span style=\"font-size:12.0pt;\">Medial geniculate body</span></li><li><span style=\"font-size:12.0pt;\">Auditory cortex</span></li></ol></li><li><span style=\"font-size:12.0pt;\">The spiral ganglion situated in Rosenthal's canal contains bipolar cells. The dendrites of these bipolar cells join to form the cochlear branch of the vestibulocochlear nerve which ends in the cochlear nuclei.</span></li></ul>",
      "correct_choice_id": 17247,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6490,
      "choices": [
        {
          "id": 25929,
          "text": "<p><span style=\"font-size:12.0pt;\">Cetirizine</span></p>"
        },
        {
          "id": 25930,
          "text": "<p><span style=\"font-size:12.0pt;\">Promethazine</span></p>"
        },
        {
          "id": 25931,
          "text": "<p><span style=\"font-size:12.0pt;\">Misolastine</span></p>"
        },
        {
          "id": 25932,
          "text": "<p><span style=\"font-size:12.0pt;\">Loratidine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following drugs is used for the prophylaxis of motion sickness?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2020)</span></p>",
      "unique_key": "Q7484884",
      "question_audio": null,
      "question_video": null,
      "map_id": 13762168,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Promethazine</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The drug that is used for the prophylaxis of motion sickness is Promethazine.</span></li><li><span style=\"font-size:12.0pt;\">Promethazine is an H1 receptor antagonist with anticholinergic, sedative, and antiemetic properties. It works by blocking the action of histamine in the brain, reducing the symptoms of nausea, vomiting, and dizziness associated with motion sickness.</span></li><li><span style=\"font-size:12.0pt;\">Other drugs used for the treatment of motion sickness include scopolamine (DOC), dimenhydrinate and meclizine, which also have antihistamine properties.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Cetirizine</strong>: Cetirizine is a second-generation antihistamine primarily used for the treatment of allergic rhinitis, hives, and other allergic conditions. It lacks significant sedative and antiemetic effects and is not typically used for motion sickness.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Misolastine</strong>: Misolastine is another second-generation antihistamine used for allergic conditions but is not indicated for motion sickness due to its lack of sedative and antiemetic properties.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Loratadine</strong>: Loratadine is also a second-generation antihistamine used for allergic conditions. Similar to cetirizine and misolastine, it does not possess the sedative and antiemetic effects required to treat motion sickness.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Promethazine is used for the prophylaxis of motion sickness due to its strong antihistamine, anticholinergic, sedative, and antiemetic properties. Second-generation antihistamines like cetirizine, misolastine, and loratadine are not effective for this purpose due to their lack of these properties.</span></p>",
      "correct_choice_id": 25930,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3559,
      "choices": [
        {
          "id": 14215,
          "text": "<p><span style=\"font-size:12.0pt;\">Line probe assay</span></p>"
        },
        {
          "id": 14216,
          "text": "<p><span style=\"font-size:12.0pt;\">CBNAAT</span></p>"
        },
        {
          "id": 14217,
          "text": "<p><span style=\"font-size:12.0pt;\">Liquid culture</span></p>"
        },
        {
          "id": 14218,
          "text": "<p><span style=\"font-size:12.0pt;\">None of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient was sputum negative for tuberculosis, but chest X-ray was suggestive of tuberculosis. Which is the next step according to RNTCP? (INICET NOV 2017)</span></p>",
      "unique_key": "Q7848660",
      "question_audio": null,
      "question_video": null,
      "map_id": 13762169,
      "difficulty_level": "beginner",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) CBNAAT</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">CB-NAAT and Line probe assay are rapid molecular diagnostic techniques used for diagnosis of tuberculosis and also to assess resistance to isoniazid and rifampicin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">CB NAAT (Cartridge Based Nucleic Acid Amplification Test) provides rapid and accurate diagnosis of TB by detecting Mycobacterium tuberculosis and mutations responsible for rifampicin resistance. It can be used for sputum samples as well as samples from extrapulmonary sites.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">It is mainly used for diagnosis of DR-TB in presumptive DR-TB patients and TB in key populations such as pediatric population, PLHIV and extrapulmonary TB.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">It is done when smear is negative for TB but chest X-ray is suggestive of tuberculosis and also in cases smear is negative and chest X-ray is not suggestive of TB but there is high index of clinical suspicion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Line probe assay:&nbsp;</strong>Line probe assay is another molecular diagnostic test used for detecting resistance to first-line and second-line anti-TB drugs. However, it is not the first choice for initial diagnosis following a negative sputum smear but suggestive chest X-ray.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Liquid culture:&nbsp;</strong>Liquid culture is used for confirming TB diagnosis and drug susceptibility testing. It is more time-consuming compared to molecular tests like CBNAAT.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For patients with negative sputum smears but chest X-ray findings suggestive of TB, CBNAAT is the recommended next diagnostic step under RNTCP guidelines.</span></p>",
      "correct_choice_id": 14216,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "CriteriaBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61860,
      "choices": [
        {
          "id": 246709,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">12-18 months</span></span></span></p>"
        },
        {
          "id": 246710,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">18-24 months</span></span></span></p>"
        },
        {
          "id": 246711,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">24-30 months</span></span></span></p>"
        },
        {
          "id": 246712,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">30-36 months</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A pediatrician is assessing the growth milestones of a child during a routine health visit. The parents are curious about the child&rsquo;s growth pattern and wonder how close the child is to reaching significant growth milestones. The pediatrician explains that certain ages are critical for reaching specific percentages of adult height. At what age does a child typically attain half of their adult height?</span></span></span></p>",
      "unique_key": "Q1392426",
      "question_audio": null,
      "question_video": null,
      "map_id": 13762170,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Answer: B) 18-24 months</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Children generally attain half of their adult height between the ages of 18 to 24 months. Monitoring growth accurately during this period is crucial for assessing normal development and identifying any growth concerns early.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Growth Milestone: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Children attain half of their adult height by 20-24 months of age.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Measuring Techniques:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">For children under 2 years, length is measured using an <strong>infantometer or rigid measuring table.</strong> The infant&rsquo;s head is held against a fixed headboard, legs are straightened, and feet are positioned at right angles with toes pointing upwards. Measurement techniques like using cloth tapes or measuring on a mattress are inaccurate and not recommended.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">For children over 2 years, height is measured by asking the child to stand upright with heels, buttocks, shoulder blades, and head against a vertical surface, using a stadiometer or measuring rod. The child should look forward, and the headpiece should be firmly placed over the head to compress the hair.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Growth Monitoring:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Plotting height and weight on a growth chart helps determine if the child is growing normally for their age and identifies factors affecting growth. Growth charts are routinely used during vaccination visits, minor illness visits, and school health programs.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Regular monitoring of growth helps detect potential growth problems early, such as growth delays, excessive weight gain, or failure to thrive, allowing for timely intervention and management.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Children typically reach half of their adult height between 18-24 months. Accurate measurement and regular monitoring during this critical period help ensure the child is growing normally, facilitating early detection and management of any growth-related issues.</span></span></span></p>",
      "correct_choice_id": 246710,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20265,
      "choices": [
        {
          "id": 81021,
          "text": "<p><span style=\"font-size:12.0pt;\">Basal cell carcinoma</span></p>"
        },
        {
          "id": 81022,
          "text": "<p><span style=\"font-size:12.0pt;\">Kaposi sarcoma</span></p>"
        },
        {
          "id": 81023,
          "text": "<p><span style=\"font-size:12.0pt;\">Malignant melanoma</span></p>"
        },
        {
          "id": 81024,
          "text": "<p><span style=\"font-size:12.0pt;\">Squamous cell carcinoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 50-year-old HIV patient presented with a painful lesion, as shown in the image. What is the most likely diagnosis? (NEET PG 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/31/screenshot-2024-07-30-170516.jpg\" alt=\"\" width=\"300\" height=\"303\"></span></p>",
      "unique_key": "Q6522920",
      "question_audio": null,
      "question_video": null,
      "map_id": 13762171,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;B. Kaposi sarcoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Kaposi sarcoma (KS) is a common malignancy in patients with HIV/AIDS. It is caused by human herpesvirus 8 (HHV-8) and typically presents as painless or painful, violaceous (purple) lesions on the skin and mucous membranes, including the oral cavity. The image shows such a lesion on the palate, which is characteristic of Kaposi sarcoma. These lesions are vascular in nature and can vary in color from red to purple, often with a raised or nodular appearance. In HIV patients, Kaposi sarcoma is an AIDS-defining condition and is often seen in those with significant immunosuppression.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A. Basal cell carcinoma:</strong> This type of skin cancer usually occurs in sun-exposed areas of the skin and rarely affects mucous membranes. It typically presents as a pearly or waxy bump, not as multiple purple lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. Malignant melanoma:</strong> While melanomas can appear as pigmented lesions, they are usually black or brown and rarely present as multiple violaceous lesions in the oral cavity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Squamous cell carcinoma:</strong> This type of cancer can occur in the oral cavity but usually presents as a non-healing ulcer or a raised, firm, scaly plaque. It does not have the characteristic color and appearance of Kaposi sarcoma lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Kaposi sarcoma should be suspected in HIV patients presenting with violaceous lesions on the skin or mucous membranes. It is an AIDS-defining condition associated with HHV-8 infection.</span></p>",
      "correct_choice_id": 81022,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54675,
      "choices": [
        {
          "id": 218165,
          "text": "<p><span style=\"font-size:12.0pt;\">Dysfunctional beliefs</span></p>"
        },
        {
          "id": 218166,
          "text": "<p><span style=\"font-size:12.0pt;\">Cognitive distortions</span></p>"
        },
        {
          "id": 218167,
          "text": "<p><span style=\"font-size:12.0pt;\">Introjection</span></p>"
        },
        {
          "id": 218168,
          "text": "<p><span style=\"font-size:12.0pt;\">Automatic negative thoughts</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following are components of Beck's cognitive theory of depression except:&nbsp;(INICET MAY 2024)</span></p>",
      "unique_key": "Q4405881",
      "question_audio": null,
      "question_video": null,
      "map_id": 13762172,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>C) Introjection</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Introjection</strong> is a psychological process where a person unconsciously adopts the ideas or attributes of other people or objects. This is often discussed in psychoanalytic contexts, not cognitive ones.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">It involves internalizing aspects of others, such as a child internalizing aspects of a lost parent, leading to complex emotional outcomes, which might contribute to the development of depressive feelings.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Beck's cognitive theory of depression posits that negative thoughts, cognitive distortions, and dysfunctional beliefs are central to the development and maintenance of depression.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.&nbsp;Dysfunctional beliefs</strong> are ingrained, maladaptive beliefs developed over time, often from childhood experiences, that can trigger depression when activated by stress.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B.&nbsp;Cognitive distortions</strong> are systematic errors in thinking, such as all-or-nothing thinking or overgeneralization, which negatively influence one's perception of reality.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.&nbsp;Automatic negative thoughts&nbsp;</strong>are recurring negative thoughts that occur spontaneously and contribute to the persistence of depressive symptoms.</span></p><p style=\"margin-left:24px;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Introjection is not a component of Beck's cognitive theory of depression; it is associated with psychoanalytic theory, which focuses on internalized feelings towards an object, such as a parent, and is less commonly used in contemporary understanding of depression.</span></p>",
      "correct_choice_id": 218167,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24717,
      "choices": [
        {
          "id": 98829,
          "text": "<p><span style=\"font-size:12.0pt;\">The trial investigated NSCLC treatment using a combination of pembrolizumab and chemotherapy.</span></p>"
        },
        {
          "id": 98830,
          "text": "<p><span style=\"font-size:12.0pt;\">The trial focused solely on the use of pembrolizumab for treating NSCLC.</span></p>"
        },
        {
          "id": 98831,
          "text": "<p><span style=\"font-size:12.0pt;\">The study explored the efficacy of combining nivolumab and chemotherapy for NSCLC.</span></p>"
        },
        {
          "id": 98832,
          "text": "<p><span style=\"font-size:12.0pt;\">The trial looked at nivolumab as a treatment option for NSCLC.</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">An oncologist is discussing with a colleague about the latest evidence-based approaches to treating non-small cell lung cancer (NSCLC). The KEYNOTE-189 trial comes up in their conversation. Which of the following accurately describes the focus of the KEYNOTE-189 trial? (</span>INICET May 2023)</p>",
      "unique_key": "Q6873833",
      "question_audio": null,
      "question_video": null,
      "map_id": 13762173,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. The trial investigated NSCLC treatment using a combination of pembrolizumab and chemotherapy.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The KEYNOTE trials are a series of clinical studies investigating the use of pembrolizumab, an immune checkpoint inhibitor, in various types of cancer. Pembrolizumab targets the PD-1 receptor, thereby enabling the immune system to better recognize and attack cancer cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. The trial focused solely on the use of pembrolizumab for treating NSCLC</strong>: This is incorrect. The KEYNOTE-189 trial investigated pembrolizumab in combination with chemotherapy, not as a monotherapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. The study explored the efficacy of combining nivolumab and chemotherapy for NSCLC</strong>: This is incorrect. The KEYNOTE-189 trial did not involve nivolumab; it focused on pembrolizumab in combination with chemotherapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. The trial looked at nivolumab as a treatment option for NSCLC</strong>: This is incorrect. The KEYNOTE-189 trial was centered on pembrolizumab, not nivolumab.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/02/screenshot-2023-12-02-110349.png\" alt=\"\" width=\"1000\" height=\"639\"></span></p>",
      "correct_choice_id": 98829,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12514,
      "choices": [
        {
          "id": 50020,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Larger teeth</span></p>"
        },
        {
          "id": 50021,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Frontal and maxillary sinuses are larger</span></p>"
        },
        {
          "id": 50022,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Frontal and parietal eminences are larger</span></p>"
        },
        {
          "id": 50023,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Supratympanic crest is present</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following trait is a feature of the female skull? (</span>AIIMS May 2018)</p>",
      "unique_key": "Q4734781",
      "question_audio": null,
      "question_video": null,
      "map_id": 13762174,
      "difficulty_level": "beginner",
      "subjects_id": [
        10
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Frontal and parietal eminences are larger</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Remember:</strong> In general, most features are larger and more prominent in males. However, there are three features which are exceptionally larger or more prominent in females. Just remember these:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Frontal Eminence</strong> is more prominent in females&nbsp;</span></li><li><span style=\"font-size:12.0pt;\"><strong>Parietal Eminence</strong> is more prominent in females</span></li><li><span style=\"font-size:12.0pt;\"><strong>Orbits&nbsp;</strong>are larger in females</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Larger teeth:&nbsp;</strong>Incorrect. Male skulls typically have larger teeth compared to females.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Frontal and maxillary sinuses are larger:&nbsp;</strong>Incorrect. These sinuses are generally larger in males.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Supratympanic crest is present:&nbsp;</strong>Incorrect. This feature is more commonly found in male skulls.</span></p><p>&nbsp;</p><p><span style=\"background-color:#fcfcff;color:black;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"background-color:#fcfcff;color:black;font-size:12.0pt;\"><strong>General differences between male and female bones:&nbsp;</strong>There are some general features which help to differentiate male and female bones. These are applicable to most bones, hence no need to remember separately for each bone. These are</span></p><p>&nbsp;</p><p><span style=\"background-color:#fcfcff;color:black;font-size:12.0pt;\"><strong>Size:&nbsp;</strong>Male bones tend are larger than female bones.</span></p><p>&nbsp;</p><p><span style=\"background-color:#fcfcff;color:black;font-size:12.0pt;\"><strong>Texture:&nbsp;</strong>The texture of male bones can be rougher and more rugged due to increased muscle attachment areas.</span></p><p>&nbsp;</p><p><span style=\"background-color:#fcfcff;color:black;font-size:12.0pt;\"><strong>Articular Surface Size:&nbsp;</strong>Male bones may have larger articular surfaces compared to females<strong>.</strong></span></p><p>&nbsp;</p><p><span style=\"background-color:#fcfcff;color:black;font-size:12.0pt;\"><strong>Bone Markings:&nbsp;</strong>Bony markings where muscles and ligaments attach are more prominent in males.</span></p><p>&nbsp;</p><p><span style=\"background-color:#fcfcff;color:black;font-size:12.0pt;\">So for individual bones, just remember the specific features, instead of general features</span></p>",
      "correct_choice_id": 50022,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "CriteriaBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44027,
      "choices": [
        {
          "id": 175767,
          "text": "<p><span style=\"font-size:12pt;\">Diphtheria</span></p>"
        },
        {
          "id": 175768,
          "text": "<p><span style=\"font-size:12pt;\">Clostridium</span></p>"
        },
        {
          "id": 175769,
          "text": "<p><span style=\"font-size:12pt;\">Bacillus</span></p>"
        },
        {
          "id": 175770,
          "text": "<p><span style=\"font-size:12pt;\">Vibrio</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which bacterial toxin acts by interfering with EF-2 function? (INICET NOV 2023)</span></p>",
      "unique_key": "Q6983143",
      "question_audio": null,
      "question_video": null,
      "map_id": 13762175,
      "difficulty_level": "beginner",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Diphtheria</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Diphtheria toxin inhibits protein synthesis by ADP-ribosylating elongation factor 2 (EF-2), blocking its function.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Clostridium</strong>: Produces toxins, but they do not target EF-2.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Bacillus</strong>: Associated with different toxins not affecting EF-2.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Vibrio</strong>: Known for cholera toxin affecting intestinal secretion, not EF-2.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Diphtheria toxin uniquely targets EF-2, crucial for understanding its mechanism of action in causing disease by inhibiting protein synthesis.</span></p>",
      "correct_choice_id": 175767,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7043,
      "choices": [
        {
          "id": 28140,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Isoniazid</span></span></span></p>"
        },
        {
          "id": 28141,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ethionamide</span></span></span></p>"
        },
        {
          "id": 28142,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acyclovir</span></span></span></p>"
        },
        {
          "id": 28143,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vancomycin</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is a second line anti-tubercular drug? (</span></span></span>INICET May 2020)</p>",
      "unique_key": "Q4422356",
      "question_audio": null,
      "question_video": null,
      "map_id": 13762176,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Ethionamide</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ethionamide is used as a second-line treatment for tuberculosis (TB), particularly in cases of multidrug-resistant TB (MDR-TB), when the first-line drugs (like isoniazid, rifampicin, ethambutol, and pyrazinamide) are not effective or cannot be used due to resistance or side effects.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Isoniazid:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is a first-line anti-tubercular drug, widely used in the treatment of both latent and active TB infections.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Acyclovir:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Acyclovir is an antiviral medication, primarily used for the treatment of herpes simplex virus infections and not for tuberculosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Vancomycin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Vancomycin is an antibiotic used to treat serious bacterial infections caused by gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). It is not used in the treatment of tuberculosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ethionamide is a second-line anti-tubercular drug used in the management of multidrug-resistant tuberculosis (MDR-TB), whereas isoniazid is a first-line drug, and acyclovir and vancomycin are not used for tuberculosis treatment.</span></span></span></p>",
      "correct_choice_id": 28141,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13924,
      "choices": [
        {
          "id": 55657,
          "text": "<p><span style=\"font-size:12.0pt;\">Vinblastine, etoposide and bleomycin</span></p>"
        },
        {
          "id": 55658,
          "text": "<p><span style=\"font-size:12.0pt;\">Vinblastine, vincristine and etoposide</span></p>"
        },
        {
          "id": 55659,
          "text": "<p><span style=\"font-size:12.0pt;\">Vinblastine, vincristine and cisplatin</span></p>"
        },
        {
          "id": 55660,
          "text": "<p><span style=\"font-size:12.0pt;\">Vincristine, carboplatin and etoposide</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following regimen is commonly used in the treatment of retinoblastoma? (NEET PG 2019)</span></p>",
      "unique_key": "Q2256328",
      "question_audio": null,
      "question_video": null,
      "map_id": 13762177,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. Vincristine, carboplatin and etoposide</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Chemotherapy commonly used is a three-drug regimen containing vincristine, carboplatin, and etoposide.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Treatment of retinoblastoma –</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/08/screenshot-2023-11-08-163719.png\" alt=\"\" width=\"1000\" height=\"726\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other 3 Options:&nbsp;</strong>Not commonly used for retinoblastoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The most commonly used chemotherapy regimen for retinoblastoma includes vincristine, carboplatin, and etoposide. This combination is effective in reducing tumor size and facilitating further local treatment options.</span></p>",
      "correct_choice_id": 55660,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61861,
      "choices": [
        {
          "id": 246713,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Complete blood count (CBC)</span></span></span></p>"
        },
        {
          "id": 246714,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hemoglobin electrophoresis</span></span></span></p>"
        },
        {
          "id": 246715,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bone marrow biopsy</span></span></span></p>"
        },
        {
          "id": 246716,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Globin gene sequencing</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 14-month-old child presents with a history of repeated blood transfusions, with the last transfusion given at 9 months of age. Laboratory evaluation reveals hemoglobin of 6.3 g/dL. Peripheral blood smear shows target cells, as depicted in the image. Based on the clinical presentation, which of the following investigations is used for a definitive diagnosis?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/19/picture3.jpg\" style=\"height:242px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q1590657",
      "question_audio": null,
      "question_video": null,
      "map_id": 13762178,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Answer: D) Globin gene sequencing</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The clinical presentation of severe anemia requiring repeated blood transfusions and the presence of target cells on the blood smear is highly suggestive of thalassemia, an inherited hemoglobin disorder. Thalassemia affects the production of alpha or beta-globin chains, leading to ineffective erythropoiesis and hemolysis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Thalassemia Diagnosis:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> The severity of the disease correlates with the number of affected globin chain genes. Each individual normally has 4 alpha-chain genes and 2 beta-chain genes. Mutations in these genes can lead to alpha- or beta-thalassemia, with varying severity based on the number of mutated genes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Definitive Diagnosis:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> The definitive test for diagnosing thalassemia is <strong>globin gene sequencing</strong>, which identifies specific genetic mutations affecting globin chain production. This test provides accurate diagnosis and helps guide management and genetic counseling.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hemoglobin Levels in Thalassemia:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Normal: HbA = 95%, HbA2 = 3.5%, HbF = 1.5%</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Beta-thalassemia trait: HbA = 90%, HbA2 = 5%, HbF = 5%</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Beta-thalassemia intermedia: HbA = 45%, HbA2 = 5%, HbF = 50%</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Screening Tests:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hemoglobin Electrophoresis:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Commonly used for newborn screening and identifies abnormal hemoglobin patterns, but it is not definitive for diagnosing specific thalassemia mutations.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">High-Performance Liquid Chromatography (HPLC):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Another screening test for detecting abnormal hemoglobin levels but not specific for identifying genetic mutations.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A) Complete blood count (CBC):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Provides initial information on anemia but does not confirm the diagnosis of thalassemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B) Hemoglobin electrophoresis:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Useful for identifying abnormal hemoglobin patterns but not definitive for thalassemia diagnosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C) Bone marrow biopsy:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Not typically used for diagnosing thalassemia; more relevant for other hematological conditions like leukemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Globin gene sequencing is the definitive diagnostic test for thalassemia, providing precise identification of the genetic mutations affecting globin chain production. This test is essential for confirming the diagnosis, guiding treatment, and offering genetic counseling to affected families.</span></span></span></p>",
      "correct_choice_id": 246716,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10073,
      "choices": [
        {
          "id": 40258,
          "text": "<p><span style=\"font-size:12.0pt;\">WASP gene mutation</span></p>"
        },
        {
          "id": 40259,
          "text": "<p><span style=\"font-size:12.0pt;\">Anti-platelet antibodies</span></p>"
        },
        {
          "id": 40260,
          "text": "<p><span style=\"font-size:12.0pt;\">Bone marrow biopsy</span></p>"
        },
        {
          "id": 40261,
          "text": "<p><span style=\"font-size:12.0pt;\">Electron microscopy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 15-year-old boy presents to the Pediatrics OPD with the complaints of several episodes of melena. On physical examination, there was eczematous rash over the skin with multiple red pin-point hemorrhagic spots. His Hemogram reveals low platelet count and normal RBC and WBC counts. What is the next best investigation?&nbsp;(INICET MAY 2022)</span></p>",
      "unique_key": "Q5726206",
      "question_audio": null,
      "question_video": null,
      "map_id": 13762179,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) WASP gene mutation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical symptoms of the patient (recurrent Melena, eczema and red pin-point hemorrhagic spots) are pointing towards the diagnosis of Wiskott-Aldrich Syndrome. It occurs due to WASP gene mutation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">So Next best step would be to analyze for WASP mutation (Chromosome Xp).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Wiskott-Aldrich syndrome is an X-linked recessive immunodeficiency disorder characterized by –</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Thrombocytopenia</span></li><li><span style=\"font-size:12.0pt;\">Recurrent bleeding (Melena, Epistaxis or Hematemesis)</span></li><li><span style=\"font-size:12.0pt;\">Low Immunity, Recurrent Infections, Eczema</span></li><li><span style=\"font-size:12.0pt;\">Low IgM and high IgA &amp; IgE</span></li><li><span style=\"font-size:12.0pt;\">Normal thymus but reduced T-cells in blood</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The only treatment for this condition is Bone Marrow Transplantation.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/picture6.jpg\" alt=\"\" width=\"500\" height=\"242\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Anti-platelet antibodies</strong>: While these are relevant in conditions like immune thrombocytopenia (ITP), they are not the primary investigation for Wiskott-Aldrich Syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Bone marrow biopsy</strong>: This can be used to assess marrow function but is not specific for diagnosing Wiskott-Aldrich Syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Electron microscopy</strong>: Although useful in some hematological disorders, it is not the first-line diagnostic tool for Wiskott-Aldrich Syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Wiskott-Aldrich Syndrome should be suspected in a pediatric patient with thrombocytopenia, eczema, and recurrent bleeding episodes, and the next best step is to investigate for a WASP gene mutation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins pathologic basis of disease 8th edition pg 439-440</strong></span></p>",
      "correct_choice_id": 40258,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10030,
      "choices": [
        {
          "id": 40086,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Kreb&#39;s cycle</span></span></span></p>"
        },
        {
          "id": 40087,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Prostaglandin</span></span></span></p>"
        },
        {
          "id": 40088,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Leukotriene</span></span></span></p>"
        },
        {
          "id": 40089,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Vitamin K</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In Which of the following pathways, cyclooxygenase is involved? </span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(INICET NOV 2022)</span></span></p>",
      "unique_key": "Q9723644",
      "question_audio": null,
      "question_video": null,
      "map_id": 13762180,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Prostaglandin</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Prostaglandins are derived from arachidonic acid, which is an essential fatty acid found in cell membranes. This process is mediated by Cyclooxygenases called, COX-1 and COX-2</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/picture7.jpg\" style=\"height:233px; width:600px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Kreb&#39;s cycle</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Kreb&#39;s cycle is the terminal pathway for the oxidative catabolism of carbohydrates, amino acids, and fatty acids.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Leukotrienes</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Leukotrienes are also produced from arachidonic acid with the help of lipoxygenases.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Vitamin K</span></strong><span style=\"font-size:12.0pt\">:<strong> </strong>Vitamin K is essential for the carboxylation of glutamate residues in certain proteins required for blood clotting. This process does not involve cyclooxygenase.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cyclooxygenase is involved in the prostaglandin synthesis pathway, converting arachidonic acid into prostaglandins, which are key mediators of inflammation, pain, and other physiological responses.</span></span></span></p>",
      "correct_choice_id": 40087,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14005,
      "choices": [
        {
          "id": 55981,
          "text": "<p><span style=\"font-size:12.0pt;\">Exposure keratopathy</span></p>"
        },
        {
          "id": 55982,
          "text": "<p><span style=\"font-size:12.0pt;\">Restricted eye movements</span></p>"
        },
        {
          "id": 55983,
          "text": "<p><span style=\"font-size:12.0pt;\">Diplopia</span></p>"
        },
        {
          "id": 55984,
          "text": "<p><span style=\"font-size:12.0pt;\">Amblyopia</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">What is the most common complication associated with the following abnormality? (</span>NEET PG 2021)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/untitled-160.jpg\" alt=\"\" width=\"300\" height=\"220\"></span></p>",
      "unique_key": "Q9115371",
      "question_audio": null,
      "question_video": null,
      "map_id": 13762181,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Exposure keratopathy</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The given image shows a coloboma of the upper eyelid. The most common complication associated with this condition is exposure keratopathy since the defect leaves the cornea exposed. If left untreated, it can lead to corneal ulceration.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>CONGENITAL EYELID COLOBOMA</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Can be unilateral or bilateral, involving one or all four lids.</span></li><li><span style=\"font-size:12.0pt;\">The defect may vary from a small marginal notch to a full-thickness absence of the entire eyelid margin involving one-third to half of the eyelid.</span></li><li><span style=\"font-size:12.0pt;\">The upper eyelid is commonly affected.</span></li><li><span style=\"font-size:12.0pt;\">The most common site is the junction between the medial and middle third of the upper eyelid.</span></li><li><span style=\"font-size:12.0pt;\">Eyelid colobomas represent an incomplete form of cryptophthalmos. Cryptophthalmos is a congenital condition in which there is a failure of differentiation of eyelid structures.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Restricted eye movements:&nbsp;</strong>This is not a primary complication of eyelid coloboma. Restricted eye movements are more associated with orbital or extraocular muscle issues.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Diplopia:&nbsp;</strong>Diplopia, or double vision, is not a common complication of eyelid coloboma. It usually arises from misalignment of the eyes or neurological conditions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Amblyopia:&nbsp;</strong>Amblyopia, or lazy eye, can occur due to vision deprivation in severe cases of eyelid abnormalities, but it is not the most common complication of eyelid coloboma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Eyelid colobomas can be an isolated finding or can be associated with various syndromes mentioned below:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/08/screenshot-2023-11-08-192933.png\" alt=\"\" width=\"1000\" height=\"530\"></span></p>",
      "correct_choice_id": 55981,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10217,
      "choices": [
        {
          "id": 40834,
          "text": "<p><span style=\"font-size:18px;\">&lt;70</span></p>"
        },
        {
          "id": 40835,
          "text": "<p><span style=\"font-size:18px;\">&lt;100</span></p>"
        },
        {
          "id": 40836,
          "text": "<p><span style=\"font-size:18px;\">&lt;50</span></p>"
        },
        {
          "id": 40837,
          "text": "<p><span style=\"font-size:18px;\">&lt;130</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>Within the framework of Sustainable Development Goal 3, the objective of target 3.1 is to achieve a reduction in the Maternal Mortality Ratio to what specific level (per 1 lakh live birts) by the year 2030? </strong><i><strong>[NEET PG 2020]</strong></i></span></p>",
      "unique_key": "Q6130945",
      "question_audio": null,
      "question_video": null,
      "map_id": 13762182,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (a) &lt;70</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">In Sustainable Development Goal 3, the target 3.1 aims to reduce the Maternal Mortality Ratio by 2030 to &lt;70 per 1 lakh live births.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/03/screenshot-2023-10-03-173901.jpg\" alt=\"\" width=\"716\" height=\"442\"></span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>SDGs – Targets &amp; Indicators</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">3.1 - By 2030, MMR &lt; 70</span></p><p><span style=\"font-size:18px;\">3.2 - By 2030, NNMR 12 &amp; U5MR 25</span></p><p><span style=\"font-size:18px;\">3.3 - By 2030, end epidemics of AIDS, TB, Malaria and NTDs and combat Hepatitis, Water-borne diseases and other CDS.</span></p><p><span style=\"font-size:18px;\">3.4 - By 2030, reduce by 1/3 premature mortality from NCDs.</span></p><p><span style=\"font-size:18px;\">3.5 - Strengthen the prevention &amp; treatment of substance abuse.</span></p><p><span style=\"font-size:18px;\">3.6 - By 2020, halve the global deaths and injuries form RTA.</span></p><p><span style=\"font-size:18px;\">3.7 - By 2030, universal access to Sexual &amp; Rep – health care services.</span></p><p><span style=\"font-size:18px;\">3.8 - Achieve Universal health coverage.</span></p><p><span style=\"font-size:18px;\">3.9 - By 2030, reduce the number of deaths, illnesses form hazardous chemicals and air, water and soil pollution and contamination.</span></p>",
      "correct_choice_id": 40834,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6889,
      "choices": [
        {
          "id": 27524,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Slowly taper the drug over next 6 months</span></span></span></p>"
        },
        {
          "id": 27525,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Continue levetiracetam since a 5-year seizure free interval is needed</span></span></span></p>"
        },
        {
          "id": 27526,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Stop levetiracetam and start on a different anti-epileptic</span></span></span></p>"
        },
        {
          "id": 27527,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Discontinue the drug as he is seizure free</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">An epileptic patient on levetiracetam has been seizure-free for 2 years. But he develops agitation and anger issues interfering with his day-to-day activities as a result of the drug intake. Which of the following measures is to be taken next? (</span></span></span>AIIMS Nov 2017)</p>",
      "unique_key": "Q6274359",
      "question_audio": null,
      "question_video": null,
      "map_id": 13762183,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Slowly taper the drug over next 6 months</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Levetiracetam is an antiepileptic drug that binds to SV2A on the vesicles and modulates the release of Neurotransmitters. It can cause anger, agitation and mood disturbances as a side effect. In such cases, the drug should be gradually tapered over the next 6 months, but not abruptly stopped as that might lead to rebound seizures.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Rationale for Tapering:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Side Effects:</span></strong><span style=\"font-size:12.0pt\"> The patient is experiencing significant side effects (agitation and anger) that are interfering with daily activities.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Seizure-Free Period:</span></strong><span style=\"font-size:12.0pt\"> While the patient has been seizure-free for 2 years, abruptly stopping the medication could lead to rebound seizures.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Gradual Tapering:</span></strong><span style=\"font-size:12.0pt\"> Tapering the medication slowly over the next 6 months is a safer approach. It allows the patient&#39;s body to adjust and reduces the risk of withdrawal seizures.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Continue levetiracetam since a 5-year seizure-free interval is needed:&nbsp;</span></strong><span style=\"font-size:12.0pt\">While a longer seizure-free interval might be ideal, continuing the medication despite significant side effects is not practical. The patient&rsquo;s quality of life is important, and the side effects need to be addressed.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Stop levetiracetam and start on a different anti-epileptic:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Abruptly stopping levetiracetam is not recommended due to the risk of withdrawal seizures. Switching to a different antiepileptic drug (AED) should be done cautiously, and often a cross-tapering strategy is used.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Discontinue the drug as he is seizure-free:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Discontinuing the drug abruptly is not advisable, even if the patient has been seizure-free, because it could trigger rebound seizures. A gradual tapering is always preferred.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">When a patient on levetiracetam experiences significant psychiatric side effects, the best approach is to slowly taper the medication over several months to prevent rebound seizures and address the side effects.</span></span></span></p>",
      "correct_choice_id": 27524,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20339,
      "choices": [
        {
          "id": 81317,
          "text": "<p><span style=\"font-size:12.0pt;\">Phenylketonuria</span></p>"
        },
        {
          "id": 81318,
          "text": "<p><span style=\"font-size:12.0pt;\">Cystic fibrosis</span></p>"
        },
        {
          "id": 81319,
          "text": "<p><span style=\"font-size:12.0pt;\">Gaucher's disease</span></p>"
        },
        {
          "id": 81320,
          "text": "<p><span style=\"font-size:12.0pt;\">Osteogenesis imperfecta</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In which disease among the following, Chloride level in sweat is evaluated? (NEET PG 2023)</span></p>",
      "unique_key": "Q3329975",
      "question_audio": null,
      "question_video": null,
      "map_id": 13762184,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Cystic fibrosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The chloride level of sweat is evaluated in cystic fibrosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">CYSTIC FIBROSIS</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Autosomal recessive</span></li><li><span style=\"font-size:12.0pt;\">Mutation in chromosome no. 7</span></li><li><span style=\"font-size:12.0pt;\">Primary defect: CFTR gene [Cystic fibrosis transmembrane conductance regulator gene on chromosome 7q31.2]</span></li><li><span style=\"font-size:12.0pt;\">Other defects: Chloride channels, Potassium channels, Epithelial sodium channels</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/01/whatsapp-image-2023-06-12-at-19012107.jpg\" alt=\"\" width=\"700\" height=\"413\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Sweat ducts normally absorb sodium from lumen which decreases in CF causing salty sweat.</span></li><li><span style=\"font-size:12.0pt;\">Excessive loss of salt in the sweat is there. Other ducts are obstructed.</span></li></ul><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Clinical Features:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hallmark of cystic fibrosis –</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">High sodium and chloride levels Sweat chloride level is &gt;60mEq/L in 2 occasions Airways, pancreas &amp; GIT - Normally sodium uptake is there from luminal fluid but in CF there is increase of sodium and water uptake from lumen causing thick, viscid secretions.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/16/screenshot-2024-09-16-153536.png\" alt=\"\" width=\"1000\" height=\"807\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Diagnostic Criteria for Cystic Fibrosis:</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/16/screenshot-2024-09-16-153658.png\" alt=\"\" width=\"1000\" height=\"244\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Phenylketonuria</strong>: Phenylketonuria occurs due to absence of phenylalanine hydroxylase enzyme, leading to phenylketonuria. Diagnosis is made by Ferric chloride test, Guthrie test.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Gaucher's disease</strong>: Gaucher disease occurs due to the deficiency of the tissue enzyme glucocerebrosidase that splits glucose from glucosylceramide, resulting in accumulation of the latter in cells of the reticuloendothelial system. Diagnosis is made by measuring glucocerebrosidase levels in leukocytes or skin fibroblasts. Serum chitotriosidase levels are elevated.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Osteogenesis imperfecta</strong>: Osteogenesis imperfecta causes defective type-1 collagen. Presents with a triad of blue sclera, Fragile bones, Early deafness.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The chloride level in sweat is evaluated to diagnose cystic fibrosis, where elevated levels indicate the disease.</span></p>",
      "correct_choice_id": 81318,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54509,
      "choices": [
        {
          "id": 217505,
          "text": "<p><span style=\"font-size:12.0pt;\">Reed Sternberg cells are of B cell origin</span></p>"
        },
        {
          "id": 217506,
          "text": "<p><span style=\"font-size:12.0pt;\">Reed Sternberg cells are CD30+ and PAX 5+</span></p>"
        },
        {
          "id": 217507,
          "text": "<p><span style=\"font-size:12.0pt;\">Nodular sclerosis HL commonly involves the mediastinum</span></p>"
        },
        {
          "id": 217508,
          "text": "<p><span style=\"font-size:12.0pt;\">Commonest site for HL is the Waldeyer ring</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is an incorrect statement about Hodgkin lymphoma (HL) ?</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q7189213",
      "question_audio": null,
      "question_video": null,
      "map_id": 13762185,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Commonest site for HL is the Waldeyer ring</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hodgkin lymphoma (HL) is characterized by the presence of Reed Sternberg cells, which are of B cell origin. These cells typically express CD30 and PAX 5 markers. The nodular sclerosis subtype of HL often involves the mediastinum, where Reed Sternberg cells are referred to as lacunar cells due to their unique appearance in this subtype. However, the statement that the commonest site for HL is the Waldeyer ring is incorrect. The Waldeyer ring is more commonly involved in non-Hodgkin lymphoma (NHL). HL typically affects the cervical, mediastinal, axillary, and inguinal lymph nodes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Reed Sternberg cells are of B cell origin:&nbsp;</strong>Correct. Reed Sternberg cells, the hallmark of Hodgkin lymphoma, originate from B cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Reed Sternberg cells are CD30+ and PAX 5+:&nbsp;</strong>Correct. Reed Sternberg cells express CD30 and PAX 5 markers, which are used in diagnosing Hodgkin lymphoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Nodular sclerosis HL commonly involves the mediastinum:&nbsp;</strong>Correct. The nodular sclerosis subtype of Hodgkin lymphoma frequently involves the mediastinum.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hodgkin lymphoma typically involves the cervical, mediastinal, axillary, and inguinal lymph nodes. The involvement of the Waldeyer ring is more characteristic of non-Hodgkin lymphoma</span></p>",
      "correct_choice_id": 217508,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5708,
      "choices": [
        {
          "id": 22804,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Doxycycline</span></span></span></p>"
        },
        {
          "id": 22805,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amoxicillin</span></span></span></p>"
        },
        {
          "id": 22806,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fluconazole</span></span></span></p>"
        },
        {
          "id": 22807,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metronidazole</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 25-year-old female came with complaints of greenish discharge per vagina and on examination she had a strawberry cervix. Which of the following is the treatment for her?&nbsp;(INICET MAY 2017)</span></span></p>",
      "unique_key": "Q8044187",
      "question_audio": null,
      "question_video": null,
      "map_id": 13762186,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Metronidazole</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The clinical presentation of greenish-yellow discharge and a strawberry cervix is characteristic of trichomoniasis. Trichomoniasis is a sexually transmitted infection caused by the protozoan Trichomonas vaginalis. The diagnostic feature of trichomoniasis includes the presence of motile flagellate organisms on a wet mount microscopy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Characteristic findings:</span></strong></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Colour of discharge:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Greenish yellow</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">On examination:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Strawberry cervix and vagina</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">pH:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> &gt;5</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diagnosis (Wet mount):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Motile flagellate organism</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Treatment:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The recommended treatment for trichomoniasis is metronidazole. It can be administered as a single dose of 2g or 200mg TDS for 7 days.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Doxycycline:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This antibiotic is used to treat various bacterial infections, including some sexually transmitted infections, but it is not the treatment of choice for trichomoniasis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Amoxicillin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This antibiotic is used for bacterial infections but is not effective against trichomoniasis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Fluconazole:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This antifungal medication is used to treat candidiasis, not trichomoniasis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Strawberry cervix and greenish-yellow vaginal discharge are characteristic of trichomoniasis, which is treated with metronidazole.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/03/screenshot-2024-08-03-154323.png\" style=\"height:447px; width:1000px\" /></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Strawberry cervix and vagina are characteristic of Trichomoniasis</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 164, DC Dutta&rsquo;s Textbook of Gynecology 6<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 22807,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61862,
      "choices": [
        {
          "id": 246717,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Serum calcium level</span></span></span></p>"
        },
        {
          "id": 246718,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Serum potassium level</span></span></span></p>"
        },
        {
          "id": 246719,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Serum bilirubin level</span></span></span></p>"
        },
        {
          "id": 246720,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serum creatinine level</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A newborn infant of a diabetic mother is being monitored in the neonatal unit due to the increased risk of complications associated with maternal diabetes. The infant appears irritable, has poor feeding, and initial blood glucose is measured at 60 mg/dL. Recognizing that infants born to diabetic mothers are at risk for various metabolic disturbances, the healthcare team decides to perform further evaluations. Which additional investigation is most appropriate for this infant?</span></span></span></p>",
      "unique_key": "Q8756013",
      "question_audio": null,
      "question_video": null,
      "map_id": 13762207,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Answer: A) Serum calcium level</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Infants born to diabetic mothers are at increased risk for several metabolic disturbances, including hypoglycemia, hypocalcemia, and hypomagnesemia. Although this infant&rsquo;s blood glucose is within an acceptable range, it is important to assess serum calcium levels because hypocalcemia is common in these infants.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Risk Factors for Infants of Diabetic Mothers:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Infants of diabetic mothers are prone to hypoglycemia, hypocalcemia, and hypomagnesemia due to the maternal metabolic influences and adaptations during fetal development.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hypocalcemia in Neonates:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hypocalcemia is defined as low levels of total serum calcium, with a cutoff of less than 8 mg/dL for term infants and less than 7 mg/dL for preterm infants.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This condition occurs due to lower levels of parathyroid hormone (PTH) in infants of diabetic mothers compared to normal infants after birth. In utero, higher levels of serum ionized calcium may suppress the fetal parathyroid glands, contributing to this condition.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Clinical Implications of Hypocalcemia:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">If left undiagnosed and untreated, hypocalcemia can lead to neurological symptoms, including irritability, poor feeding, seizures, or other neurologic deficits.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Evaluation of Infants at Risk:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In infants born to diabetic mothers, it is recommended to estimate the serum calcium level to rule out hypocalcemia, even if initial symptoms are subtle or not immediately severe.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B) Serum potassium level:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Potassium levels are not specifically affected in infants of diabetic mothers, making this less relevant for immediate evaluation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C) Serum bilirubin level:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Elevated bilirubin is common in newborns but does not directly relate to maternal diabetes and the immediate concerns of hypocalcemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D) Serum creatinine level:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Used to assess kidney function, but it is not directly relevant to the primary metabolic risks associated with infants of diabetic mothers.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Infants born to diabetic mothers should be evaluated for hypocalcemia due to their increased risk, which is influenced by maternal metabolic factors and fetal adaptations. Early detection through serum calcium measurement is essential to prevent neurological complications and ensure proper management.</span></span></span></p>",
      "correct_choice_id": 246717,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6119,
      "choices": [
        {
          "id": 24445,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vacuum-assisted delivery </span></span></span></p>"
        },
        {
          "id": 24446,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cesarean section </span></span></span></p>"
        },
        {
          "id": 24447,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Normal vaginal delivery </span></span></span></p>"
        },
        {
          "id": 24448,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Forceps delivery</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A primigravida presents to the emergency room in the early stage of labor with adequate uterine contractions. On per vaginal examination, a gynecoid pelvis is felt, the membranes are ruptured, and the vertex is felt in the right occipito-posterior position. How will you manage this patient?</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;</span></span>(NEET PG 2022)</p>",
      "unique_key": "Q6805440",
      "question_audio": null,
      "question_video": null,
      "map_id": 13762208,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Normal vaginal delivery </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Normal vaginal delivery:</span></strong></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Assuming the patient has no other complications, such as fetal distress or cephalopelvic disproportion, the given features of right occipito-posterior presentation with a favorable pelvis (gynecoid) and adequate uterine contractions can be managed by normal vaginal delivery.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In 90% of circumstances with a favorable pelvis and strong uterine contractions, without any complications, the occipito-posterior position can undergo the mechanism of normal labor.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient can be closely monitored for the progress of normal vaginal delivery. However, if complications arise or labor stalls, alternative methods such as vacuum-assisted delivery or forceps delivery may be considered. A cesarean section would only be necessary if there were complications that prevented a safe vaginal delivery.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Vacuum-assisted delivery:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vacuum-assisted delivery is generally considered when there is prolonged second stage of labor or fetal distress. In this case, since there are no complications mentioned and the pelvis is favorable, normal vaginal delivery is the preferred option.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Cesarean section:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A cesarean section is usually considered when there is cephalopelvic disproportion, fetal distress, or failure to progress in labor. Given the favorable conditions in this scenario, a normal vaginal delivery is feasible.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Forceps delivery:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Forceps delivery, like vacuum-assisted delivery, is used in cases of prolonged second stage of labor or when there is a need to expedite delivery. In the absence of such complications, normal vaginal delivery is the appropriate management.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Right occipito-posterior presentation with a favorable pelvis and adequate uterine contractions in a primigravida can be managed by closely monitoring for a normal vaginal delivery, provided there are no complications.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 89, Williams Obstetrics 26<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 24447,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7038,
      "choices": [
        {
          "id": 28120,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oxycodone</span></span></span></p>"
        },
        {
          "id": 28121,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clarithromycin</span></span></span></p>"
        },
        {
          "id": 28122,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adalimumab</span></span></span></p>"
        },
        {
          "id": 28123,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rivoraxaban</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rosuvastatin should not be combined with which of the following drugs? (</span></span>INICET May 2020)</p>",
      "unique_key": "Q9105179",
      "question_audio": null,
      "question_video": null,
      "map_id": 13762209,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Clarithromycin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Statins are metabolized by CYP3A4 enzyme, which is inhibited by clarithromycin. The plasma levels of statins may rise to high levels if used with clarithromycin, resulting in serious adverse effects like myopathy.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>A</strong>. <strong>Oxycodone: </strong>Oxycodone is an opioid analgesic used for pain management. It does not interact significantly with rosuvastatin and does not affect its metabolism.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>C.</strong> <strong>Adalimumab: </strong>Adalimumab is a monoclonal antibody used to treat autoimmune conditions. It does not interfere with the metabolism of rosuvastatin and therefore is not associated with increased risk of myopathy when used in combination.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>D.</strong> <strong>Rivoraxaban: </strong>Rivaroxaban is an anticoagulant used to prevent and treat blood clots. It does not interact with the metabolism of rosuvastatin and does not pose a risk of increased myopathy.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Drugs increasing the risk of statin induced myopathy are:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amiodarone</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gemfibrozil</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HIV protease inhibitors like saquinavir, ritonavir etc.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clarithromycin</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Itraconazole</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 28121,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4233,
      "choices": [
        {
          "id": 16909,
          "text": "<p><span style=\"font-size:12.0pt;\">Saccharin test</span></p>"
        },
        {
          "id": 16910,
          "text": "<p><span style=\"font-size:12.0pt;\">Electron microscopy</span></p>"
        },
        {
          "id": 16911,
          "text": "<p><span style=\"font-size:12.0pt;\">Charcoal powder method</span></p>"
        },
        {
          "id": 16912,
          "text": "<p><span style=\"font-size:12.0pt;\">Scintigraphy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following tests cannot be used to assess nasal mucociliary clearance?</span>(INICET MAY 2022)</p>",
      "unique_key": "Q8192365",
      "question_audio": null,
      "question_video": null,
      "map_id": 13762210,
      "difficulty_level": "intermediate",
      "subjects_id": [
        9
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Electron microscopy</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Among the given options, electron microscopy will be the least useful in assessing nasal mucociliary clearance.</span></li><li><span style=\"font-size:12.0pt;\">Electron microscopy -&nbsp; can detect structural and functional abnormalities of cilia but do not detect any other abnormalities interfering with nasal mucociliary clearance. It is used to visualize the detailed architecture of cilia, which can help identify defects in ciliary structure responsible for impaired mucociliary transport, but it does not measure the actual transport or clearance function.</span></li></ul><p><img class=\"image_resized\" style=\"aspect-ratio:2000/1125;width:58.03%;\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_6XCQRnJ.png\" width=\"2000\" height=\"1125\"></p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Saccharin&nbsp;Test</strong>: This is a straightforward clinical test where a small amount of saccharin is placed on the nasal mucosa, and the time it takes for the subject to taste the sweetness is measured. This time reflects the mucociliary clearance rate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Charcoal Powder Method</strong>: Involves placing a small amount of charcoal powder in the nose and timing how long it takes for it to appear in the pharynx, similarly assessing the clearance capability of the mucociliary apparatus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Scintigraphy</strong>: This nuclear medicine test uses a small amount of radioactive material to track and record mucociliary transport and clearance, providing both functional and anatomical information about the nasal and sinus mucosa.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Test for mucociliary clearance is:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Saccharin&nbsp;with or without color test in vivo -&nbsp;&nbsp; Saccharin or another substance is placed in the nose, and the speed of transport into the nasopharynx is measured to calculate mucociliary clearance.</span></li><li><span style=\"font-size:12.0pt;\">Radioisotope transport testing in vivo</span></li><li><span style=\"font-size:12.0pt;\">Measuring ciliary activity in vitro</span></li><li><span style=\"font-size:12.0pt;\">Nasal nitric oxide -&nbsp; Measuring exhaled nasal nitric oxide, which is mostly reduced in primary ciliary dyskinesia, is a good screening test for immotile-cilia syndrome with a good negative predictive value</span></li><li><span style=\"font-size:12.0pt;\">Scintigraphy is the nuclear medicine equivalent of the dye disappearance test to assess functional and anatomic obstruction</span></li><li><span style=\"font-size:12.0pt;\">Pulmonary radioaerosol mucociliary clearance: Mucociliary transport, which is reduced in these patients, can be measured in situ by administering an inhalation aerosol of colloid albumin or colloid sulfur tagged with technetium Tc 99. This test is generally not recommended owing to the high rate of false-positive results.</span></li><li><span style=\"font-size:12.0pt;\">The charcoal method - a very small amount of charcoal is placed behind the head of the inferior turbinate. The pharynx is then observed to detect the presence of charcoal. Less commonly used.</span></li></ul></li></ul>",
      "correct_choice_id": 16910,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11704,
      "choices": [
        {
          "id": 46782,
          "text": "<p><span style=\"font-size:12.0pt;\">Cirrhosis</span></p>"
        },
        {
          "id": 46783,
          "text": "<p><span style=\"font-size:12.0pt;\">Liver failure</span></p>"
        },
        {
          "id": 46784,
          "text": "<p><span style=\"font-size:12.0pt;\">Metastasis to liver</span></p>"
        },
        {
          "id": 46785,
          "text": "<p><span style=\"font-size:12.0pt;\">TB peritonitis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient with ascites is found to have SAAG ≥ 1.1. All of the following causes except: (AIIMS NOV 2018)</span></p>",
      "unique_key": "Q3798675",
      "question_audio": null,
      "question_video": null,
      "map_id": 13762211,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) TB peritonitis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Serum-Ascites Albumin Gradient (SAAG) is calculated to differentiate between ascites caused by portal hypertension (high SAAG ≥ 1.1) and ascites caused by other reasons (low SAAG &lt; 1.1). A SAAG value ≥ 1.1 indicates that the ascites is likely due to issues related to portal hypertension, such as cirrhosis, liver failure, or metastasis to the liver, which can also cause portal hypertension. Tuberculosis peritonitis, however, typically presents with a SAAG lower than 1.1 because it is not associated with portal hypertension but rather with peritoneal inflammation and capillary leak.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Cirrhosis:&nbsp;</strong>Directly associated with portal hypertension and commonly results in a SAAG ≥ 1.1.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Liver failure:&nbsp;</strong>Often leads to portal hypertension, causing a high SAAG.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Metastasis to liver:&nbsp;</strong>Can impede hepatic blood flow and increase portal pressure, also leading to a high SAAG.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/nm114.jpg\" alt=\"\" width=\"700\" height=\"443\"></strong></span></p>",
      "correct_choice_id": 46785,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6012,
      "choices": [
        {
          "id": 24018,
          "text": "<p><span style=\"font-size:12pt;\">Crown rump length by USG</span></p>"
        },
        {
          "id": 24019,
          "text": "<p><span style=\"font-size:12pt;\">Adding 280 days to the LMP</span></p>"
        },
        {
          "id": 24020,
          "text": "<p><span style=\"font-size:12pt;\">Fundus examination</span></p>"
        },
        {
          "id": 24021,
          "text": "<p><span style=\"font-size:12pt;\">Adding 256 days to the LMP</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old woman on oral contraceptives for the past 6 months presents with 6 weeks of amenorrhea. What would be the best method of assessing the gestational age of this patient? (NEET PG 2021)</span></p>",
      "unique_key": "Q1328506",
      "question_audio": null,
      "question_video": null,
      "map_id": 13762212,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Crown rump length by USG</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Crown-Rump Length (CRL) by Ultrasound:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The most accurate method for determining gestational age in the first trimester is by measuring the Crown-Rump Length (CRL) on ultrasound. This method is reliable as it directly measures the embryo or fetus and provides a precise gestational age.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Adding 280 days to the Last Menstrual Period (LMP):</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">This method, known as Naegele’s rule, is commonly used but assumes a regular 28-day menstrual cycle and may not be accurate for women with irregular cycles or those using contraceptives.</span></li><li><span style=\"font-size:12pt;\">It is less reliable in this patient who has been on oral contraceptives, which can alter the regularity of menstrual cycles.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Fundus Examination:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Palpation of the uterine fundus is a physical examination method to estimate gestational age. However, it is less accurate in the first trimester and typically used in the second and third trimesters.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Adding 256 days to the LMP:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">This method is not standard practice and is less commonly used compared to adding 280 days to the LMP.</span></li><li><span style=\"font-size:12pt;\">It would be even less reliable in this patient who has been on oral contraceptives.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The most accurate method for determining gestational age in the first trimester is the measurement of Crown-Rump Length (CRL) on ultrasound.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 475, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 24018,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14041,
      "choices": [
        {
          "id": 56125,
          "text": "<p><span style=\"font-size:12.0pt;\">MRCP</span></p>"
        },
        {
          "id": 56126,
          "text": "<p><span style=\"font-size:12.0pt;\">ERCP (Endoscopic Retrograde Cholangiopancreatography)</span></p>"
        },
        {
          "id": 56127,
          "text": "<p><span style=\"font-size:12.0pt;\">Endoscopic ultrasound</span></p>"
        },
        {
          "id": 56128,
          "text": "<p><span style=\"font-size:12.0pt;\">Laparoscopic cholecystectomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old lady presents to the emergency department with severe abdominal pain. An abdominal ultrasound reveals the presence of multiple gallstones with no evidence of wall thickening. The bile duct (BD) diameter is measured at 12 mm, and serum bilirubin levels are mildly elevated at 0.8. The patient's alkaline phosphatase levels are significantly elevated at 380, and the gamma-glutamyl transferase (GGT) levels are raised by 5 times. What is the next best step in the management of this patient? (INICET MAY 2021)</span></p>",
      "unique_key": "Q4660803",
      "question_audio": null,
      "question_video": null,
      "map_id": 13762213,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) MRCP</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Given the patient's presentation of multiple gallstones, an enlarged bile duct diameter, and elevated liver enzymes, there is a high suspicion of choledocholithiasis (stones in the common bile duct). An MRCP is the most appropriate initial investigation to visualize and confirm the presence of common bile duct stones without subjecting the patient to an invasive procedure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>ERCP (Endoscopic Retrograde Cholangiopancreatography)</strong>: ERCP is an invasive procedure that allows both the visualization and treatment of biliary and pancreatic duct abnormalities. While it can be used to diagnose and treat choledocholithiasis, it is generally reserved for therapeutic interventions after the diagnosis has been established, given the risks associated with the procedure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Endoscopic ultrasound</strong>: This technique can be very sensitive for detecting common bile duct stones and other biliary pathologies. However, in the context of a patient with an enlarged bile duct and elevated liver enzymes suggestive of choledocholithiasis, MRCP would be the preferred initial diagnostic tool.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>. <strong>Laparoscopic cholecystectomy</strong>: While the patient may ultimately require a cholecystectomy, especially if the gallstones are the cause of her symptoms, it's crucial to first assess and manage any potential common bile duct stones. Directly proceeding to cholecystectomy without addressing potential common bile duct stones could lead to complications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In summary, given the patient's clinical presentation and laboratory findings suggesting the presence of common bile duct stones, an MRCP is the most appropriate initial step to visualize the biliary system and confirm the diagnosis.</span></p>",
      "correct_choice_id": 56125,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 1936,
      "choices": [
        {
          "id": 7737,
          "text": "<p><span style=\"font-size:12.0pt;\">Alpha ketoglutarate</span></p>"
        },
        {
          "id": 7738,
          "text": "<p><span style=\"font-size:12.0pt;\">Fumarate</span></p>"
        },
        {
          "id": 7739,
          "text": "<p><span style=\"font-size:12.0pt;\">Succinyl CoA</span></p>"
        },
        {
          "id": 7740,
          "text": "<p><span style=\"font-size:12.0pt;\">Malate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following TCA cycle intermediate is a part of heme metabolism? (</span>AIIMS May 2019)</p>",
      "unique_key": "Q5595789",
      "question_audio": null,
      "question_video": null,
      "map_id": 13762214,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Succinyl CoA</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">TCA cycle is truly amphibolic (both catabolic and anabolic) in nature.</span><span style=\"font-size:10.5pt;\"> </span><span style=\"font-size:12.0pt;\">Since various compounds enter into or leave from TCA cycle, it is sometimes called as “<strong>metabolic traffic circle</strong>”.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Succinyl CoA and Heme Synthesis:</strong></span><ul><li><span style=\"font-size:12.0pt;\"><strong>Function:</strong> Succinyl CoA combines with glycine to form delta-aminolevulinic acid (ALA), which is the first step in the synthesis of heme.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Enzyme Involved:</strong> The enzyme ALA synthase catalyzes this reaction in the mitochondria.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Importance:</strong> Heme is a vital component of hemoglobin, myoglobin, and various cytochromes involved in electron transport and drug metabolism.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Alpha Ketoglutarate:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Function:</strong> Precursor for the synthesis of glutamate and subsequently other amino acids.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Relevance:</strong> Not directly involved in heme metabolism.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Fumarate:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Function:</strong> Intermediate in the TCA cycle, involved in the conversion of fumarate to malate.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Relevance:</strong> Not directly involved in heme metabolism.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Malate:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Function:</strong> Intermediate in the TCA cycle, involved in the conversion of malate to oxaloacetate.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Relevance:</strong> Not directly involved in heme metabolism.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Important anabolic reactions</strong> related with citric acid cycle are:</span></p><ol style=\"list-style-type:upper-alpha;\"><li><span style=\"font-size:12.0pt;\"><strong>Oxaloacetate</strong> is the precursor of aspartate</span></li><li><span style=\"font-size:12.0pt;\"><strong>Alpha ketoglutarate</strong> can be made into glutamate</span></li><li><span style=\"font-size:12.0pt;\"><strong>Succinyl CoA</strong> is used for synthesis of heme</span></li><li><span style=\"font-size:12.0pt;\"><strong>Mitochondrial citrate</strong> is transported to cytoplasm, where it is cleaved into acetyl CoA, which then is the <strong>starting point of fatty acid synthesis.</strong></span></li></ol>",
      "correct_choice_id": 7739,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9892,
      "choices": [
        {
          "id": 39534,
          "text": "<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Pernicious anemia</span></span></span></p>"
        },
        {
          "id": 39535,
          "text": "<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Carcinoid syndrome</span></span></span></p>"
        },
        {
          "id": 39536,
          "text": "<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Vit B12 Deficiency</span></span></span></p>"
        },
        {
          "id": 39537,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Zollinger Ellison syndrome</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">The absence of the structure marked as A will present with all except: </span></span></span>(AIIMS NOV 2020)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/1108.jpg\" style=\"height:192px; width:300px\" /></span></span></p>",
      "unique_key": "Q8114668",
      "question_audio": null,
      "question_video": null,
      "map_id": 13762215,
      "difficulty_level": "difficult",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Zollinger Ellison syndrome</span></strong> </span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">The eosinophilic appearing cells marked as A are the parietal cells, the absence of which is not associated with Zollinger Ellison Syndrome.</span></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/1109.jpg\" style=\"height:332px; width:500px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Zollinger-Ellison syndrome is caused by gastrin-secreting tumors, gastrinomas, that are most&nbsp;</span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">commonly found in the small intestine or pancreas. Patients often present with duodenal ulcers or chronic diarrhea. Within the stomach, the most remarkable feature is a doubling of oxyntic mucosal thickness due to a fivefold increase in the number of parietal cells It is caused by gastrin-secreting neuroendocrine tumors. </span></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Pernicious anemia:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This condition is directly related to the absence or dysfunction of parietal cells, leading to a lack of intrinsic factor and B12 deficiency.</span></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Carcinoid syndrome:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> While not directly related to parietal cells, the presence or absence of parietal cells might influence gastric pH and indirectly affect gastrointestinal symptoms.</span></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Vit B12 Deficiency:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> B12 deficiency results from a lack of intrinsic factor, which is produced by parietal cells. The absence of parietal cells would lead to B12 deficiency.</span></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The <strong>absence of parietal cells</strong> is not associated with <strong>Zollinger-Ellison syndrome</strong> but can lead to <strong>Pernicious anemia</strong> and <strong>Vitamin B12 deficiency</strong>.</span></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref:&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Robbins and Cotran Pathologic basis of disease 8<sup>th</sup> edition pg 1493</span></strong></span></span></p>",
      "correct_choice_id": 39537,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7014,
      "choices": [
        {
          "id": 28024,
          "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">No advice as most of drug are not present in breast milk</span></span></p>"
        },
        {
          "id": 28025,
          "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Give longer half-life drugs</span></span></p>"
        },
        {
          "id": 28026,
          "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tell the mother to feed when it is least efficacious</span></span></p>"
        },
        {
          "id": 28027,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">To feed just before the next dose, when the plasma concentration of the drug would be the least</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What advice do you give to a mother who is using medications during lactation? (AIIMS MAY 2017)</span></span></p>",
      "unique_key": "Q6141993",
      "question_audio": null,
      "question_video": null,
      "map_id": 13762216,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D. To feed just before the next dose, when the plasma concentration of the drug would be the least</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">When administering medications to a lactating mother, the timing of breast feeding is very important. It is advised to feed the baby just before the intake of the drug, as at that time the plasma concentration of the drug would be least. Then after feeding the drug is taken.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. No advice as most of the drug are not present in breast milk</span></strong><span style=\"font-size:12.0pt\">: This is incorrect. Many drugs can pass into breast milk to varying degrees. Therefore, careful consideration and advice are needed to minimize infant exposure.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Give longer half-life drugs</span></strong><span style=\"font-size:12.0pt\">: This is not a general recommendation. Drugs with longer half-lives stay in the body longer and can potentially accumulate in the breast milk, increasing exposure to the infant.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Tell the mother to feed when it is least efficacious</span></strong><span style=\"font-size:12.0pt\">: This advice is not clear or practical. The key is to time breastfeeding relative to the dosing schedule to minimize drug transfer to the breast milk.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The best advice for a lactating mother using medications is to breastfeed just before taking her next dose of medication. This practice ensures that the drug&#39;s plasma concentration is at its lowest during breastfeeding, thereby reducing the amount of drug that passes into the breast milk and minimizing exposure to the infant.</span></span></p>",
      "correct_choice_id": 28027,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6737,
      "choices": [
        {
          "id": 26917,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Plasma volume</span></span></span></p>"
        },
        {
          "id": 26918,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Interstitial fluid volume</span></span></p>"
        },
        {
          "id": 26919,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">ICF</span></span></span></p>"
        },
        {
          "id": 26920,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">ECF</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">I-125 labelled albumin is used for measurement of: (</span></span>AIIMS May 2019)</p>",
      "unique_key": "Q7076588",
      "question_audio": null,
      "question_video": null,
      "map_id": 13762217,
      "difficulty_level": "intermediate",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Plasma volume</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Albumin iodinated I-125 serum is a radiopharmaceutical diagnostic agent indicated for use in the determination of total blood and plasma volume.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The use of I-125 labeled albumin for the measurement of interstitial fluid volume, intracellular fluid volume or extracellular fluid volume is not common. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other tracers, such as inulin or sucrose, are more commonly used for measuring extracellular or interstitial fluid volume, while radiolabeled water or radiolabeled potassium chloride can be used for measuring total body water and intracellular fluid volume.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Interstitial fluid volume:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Incorrect. Interstitial fluid volume is typically measured using other tracers such as inulin or thiosulfate.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. ICF (Intracellular Fluid):&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Incorrect. Intracellular fluid volume is not measured using I-125 labelled albumin. Methods like radiolabeled potassium or total body water (using deuterium or tritium) are used for ICF estimation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. ECF (Extracellular Fluid):&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Incorrect. Extracellular fluid volume is generally measured using tracers like inulin, which distribute throughout the extracellular compartment but do not enter cells.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational objective </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">I-125 labelled albumin is specifically used to measure plasma volume. It remains confined to the vascular compartment, making it an effective tracer for determining the volume of plasma within the circulatory system</span></span></p>",
      "correct_choice_id": 26917,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7132,
      "choices": [
        {
          "id": 28496,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hemophilus alters penicillin binding protein sites, hence resistant to ampicillin</span></span></span></p>"
        },
        {
          "id": 28497,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Easier to administer IV ceftriaxone than IV ampicillin</span></span></span></p>"
        },
        {
          "id": 28498,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cotrimoxazole is the drug of choice, but patient is allergic to sulfa drugs</span></span></span></p>"
        },
        {
          "id": 28499,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hemophilus produces beta lactamase, hence resistant to ampicillin</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 14-month-old boy was diagnosed with Hemophilus influenza meningitis. The initial treatment plan was to start on ampicillin but later was shifted to ceftriaxone. What could be the probable reason? (</span></span>INICET Nov 2021)</p>",
      "unique_key": "Q8119019",
      "question_audio": null,
      "question_video": null,
      "map_id": 13762218,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D. Hemophilus produces beta lactamase, hence resistant to ampicillin &nbsp;</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hemophilus influenzae, particularly some strains, can produce beta-lactamase, an enzyme that breaks down the beta-lactam ring found in penicillins (like ampicillin) and some other antibiotics. This enzymatic activity renders these bacteria resistant to the effects of these antibiotics. Due to the increasing prevalence of beta-lactamase-producing H. influenzae, the use of ampicillin alone is often not recommended for serious infections like meningitis. Ceftriaxone, a third-generation cephalosporin, is a preferred choice as it is more resistant to beta-lactamase and has good central nervous system penetration, which is essential for the treatment of meningitis.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">A. Hemophilus alters penicillin-binding protein sites, hence resistant to ampicillin:</span></strong><span style=\"font-size:12.0pt\"> While changes in penicillin-binding proteins can confer resistance to beta-lactam antibiotics, this is not the primary mechanism of resistance in H. influenzae. The major concern is beta-lactamase production.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B. Easier to administer IV ceftriaxone than IV ampicillin:</span></strong><span style=\"font-size:12.0pt\"> While the ease of administration might be a consideration in some cases (ceftriaxone can be given once a day due to its long half-life), the primary concern in this scenario is antibiotic efficacy and resistance patterns, not the convenience of administration.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">C. Cotrimoxazole is the drug of choice, but the patient is allergic to sulfa drugs:</span></strong><span style=\"font-size:12.0pt\"> Cotrimoxazole (trimethoprim-sulfamethoxazole) is not the primary drug of choice for H. influenzae meningitis. The first-line treatment is usually a third-generation cephalosporin like ceftriaxone or cefotaxime.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Therefore, the most probable reason for switching from ampicillin to ceftriaxone in this case is the beta-lactamase production by H. influenzae, making it resistant to ampicillin.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The primary reason for switching from ampicillin to ceftriaxone in the treatment of Hemophilus influenzae meningitis is the production of beta-lactamase by H. influenzae, which renders the bacteria resistant to ampicillin. Ceftriaxone is more resistant to beta-lactamase and provides effective CNS penetration, making it a more suitable choice for treating bacterial meningitis.</span></span></span></p>",
      "correct_choice_id": 28499,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11723,
      "choices": [
        {
          "id": 46858,
          "text": "<p><span style=\"font-size:12.0pt;\">Cytomegalovirus</span></p>"
        },
        {
          "id": 46859,
          "text": "<p><span style=\"font-size:12.0pt;\">Epstein-Barr virus</span></p>"
        },
        {
          "id": 46860,
          "text": "<p><span style=\"font-size:12.0pt;\">Varicella zoster virus</span></p>"
        },
        {
          "id": 46861,
          "text": "<p><span style=\"font-size:12.0pt;\">Herpes simplex virus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is the most common cause of infection post-solid organ transplantation in an Indian setting? (AIIMS NOV 2019)</span></p>",
      "unique_key": "Q8852149",
      "question_audio": null,
      "question_video": null,
      "map_id": 13762219,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A)&nbsp;Cytomegalovirus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">CMV is most common infection occurring after transplant. Risk depends on induction agent and seropositivity status. Minimal risk for D-/R-(Donor, recipient negative). Highest risk of reactivation in D-/R+ and patients who received anti-lymphocyte therapy. Prophylaxis is given pre-emptively if periodic CMV-DNA PCR are &gt;500 copies/ml with Valgan/ Foscarnet/Cidofovir. Letermovir has no hepato/nephrotoxicity (Safest)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">D-/R- patients should receive leucodepleted blood products to minimise transmission of CMV</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B.&nbsp;</strong>EBV infection occurs in 1-2% of post-transplant patients and responds well to acyclovir prophylaxis</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.&nbsp;</strong>VZV reactivation can occur at any point post-transplant</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.&nbsp;</strong>HSV occurs within 1-month post-transplant in the absence of acyclovir prophylaxis&nbsp;Nephrology/infectious diseases/post-transplant</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cytomegalovirus (CMV) is the most prevalent and clinically significant viral infection in the post-solid organ transplant setting in India, necessitating targeted prophylaxis and monitoring protocols to mitigate its risks.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Critical Care Nephrology /Chapter 95</strong></span></p>",
      "correct_choice_id": 46858,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13779,
      "choices": [
        {
          "id": 55077,
          "text": "<p><span style=\"font-size:12.0pt;\">Caudate nucleus</span></p>"
        },
        {
          "id": 55078,
          "text": "<p><span style=\"font-size:12.0pt;\">Lentiform nucleus</span></p>"
        },
        {
          "id": 55079,
          "text": "<p><span style=\"font-size:12.0pt;\">Dentate nucleus</span></p>"
        },
        {
          "id": 55080,
          "text": "<p><span style=\"font-size:12.0pt;\">Red nucleus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Purkinje cells of cerebellum relay into: (</span>AIIMS May 2018)</p>",
      "unique_key": "Q1986463",
      "question_audio": null,
      "question_video": null,
      "map_id": 13762240,
      "difficulty_level": "intermediate",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Dentate nucleus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The cerebellum's purkinje cells relay information to the dentate nucleus, one of the deep cerebellar nuclei.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">It is the cerebellum's distinguishing cell. It is a large flask-shaped cell. Climbing fibres from the inferior olivary nucleus stimulate it. This cell's main output is inhibitory in nature and is directed at cerebellar nuclei. These are the most important output neurons.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/02/ia-12.jpg\" alt=\"\" width=\"500\" height=\"280\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.</strong> <strong>Caudate Nucleus</strong>: It's one of the structures that make up the basal ganglia in the brain. The caudate nucleus has a long, C-shaped structure and is located laterally in the brain, near the lateral ventricles. It plays roles in various functions like voluntary movement control, learning, memory, and emotion. Purkinje cells do not primarily relay into the caudate nucleus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>. <strong>Lentiform Nucleus</strong>: Another component of the basal ganglia, the lentiform nucleus is located deep within the brain and is laterally placed in relation to the thalamus. The lentiform nucleus is made up of two structures: the putamen and the globus pallidus. It's involved in movement regulation and other functions. Purkinje cells do not have a direct relay into the lentiform nucleus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.</strong> <strong>Red Nucleus</strong>: Found in the midbrain, the red nucleus has a reddish hue due to its rich blood supply and the presence of iron. It plays a role in motor coordination, particularly in the coordination of limb movements. While the red nucleus does receive input from the cerebellum, the primary relay from Purkinje cells is to the deep cerebellar nuclei, not directly to the red nucleus. The dentate nucleus, in turn, can send projections to the red nucleus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Dentate Nucleus</strong> is one of the deep cerebellar nuclei and is situated within the white matter of the cerebellum. The dentate nucleus is the largest of the deep cerebellar nuclei and plays a role in the planning, initiation, and control of voluntary movements.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Purkinje cells in the cerebellar cortex send inhibitory projections to the deep cerebellar nuclei, including the dentate nucleus. This is the main output pathway for the cerebellar cortex.</span></p>",
      "correct_choice_id": 55079,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}